Page last updated: 2024-08-21

vancomycin and Antibiotic-Associated Colitis

vancomycin has been researched along with Antibiotic-Associated Colitis in 537 studies

Research

Studies (537)

TimeframeStudies, this research(%)All Research%
pre-1990146 (27.19)18.7374
1990's71 (13.22)18.2507
2000's121 (22.53)29.6817
2010's191 (35.57)24.3611
2020's8 (1.49)2.80

Authors

AuthorsStudies
Galang, MA; Gerding, DN; Hecht, DW; Johnson, S; Osmolski, JR; Sambol, SP1
Cloud, JW; Espinoza, D; Kelly, CP; Kokkotou, E; Michos, A; Moss, AC; Mustafa, N; O'Brien, M; Pothoulakis, C1
Béliveau, C; Labbé, AC; Laverdière, M; Louie, T; Maccannell, D; Pépin, J; Poirier, L; Savoie, M1
Karlowsky, JA; Laing, NM; Zhanel, GG1
Babakhani, F; Robert, N; Sears, P; Seddon, J; Shue, YK1
Amaral, A; Brewer, JT; Bushell, SM; Deng, G; Dewhurst, JM; Ding, J; Dzink-Fox, J; Gamber, G; Jain, A; LaMarche, MJ; Lee, K; Lee, L; Leeds, JA; Lister, T; McKenney, D; Mullin, S; Osborne, C; Palestrant, D; Patane, MA; Rann, EM; Sachdeva, M; Shao, J; Tiamfook, S; Trzasko, A; Whitehead, L; Yan, W; Yifru, A; Yu, D; Zhu, Q1
Citron, D; He, Y; Herradura, P; Howland, K; Keith, D; Li, J; Mascio, CT; Mesleh, MF; Metcalf, C; Mortin, LI; Pearson, A; Silverman, J; Steenbergen, J; Thorne, GM; Van Praagh, AD; Yin, N1
Stephenson, AL1
Dai, J; Gong, J; Guo, R1
Bowman, JA; Utter, GH1
Quigley, EMM1
Bai, Y; Huang, GQ; Liu, J; Sun, ZQ1
AbdelKhalek, A; Seleem, MN1
Baiu, I; Forgó, E; Kin, C; Weiser, TG1
Bidell, MR; Bratek, BR; Duru, OO; Mitchell, CL; Novak, GM; O'Donnell, JN; Roddy, KM; Singh, G1
Benea, SN; Hristea, A; Jipa, RE; Manea, E; Rodríguez-Baño, J; Sojo-Dorado, J1
Baharith, H; Ford, AC; Moayyedi, P; Yuan, Y1
Ariyoshi, N; Fujishiro, T; Hattori, N; Ishii, I; Ishikawa, M; Matsubara, H; Miyauchi, H; Oami, T; Oda, S; Suzuki, T; Takatsuka, H; Yamazaki, S1
Adomakoh, N; Aguado, JM; Anttila, VJ; Bisnauthsing, K; Cornely, OA; Georgopali, A; Goldenberg, SD; Guery, B; Karas, A; Kazeem, G; Longshaw, C; Menichetti, F; Palacios-Fabrega, JA; Vehreschild, MJGT1
Chen, X; Faull, KF; Ghali, S; Jacobs, JP; Koon, HW; Lagishetty, V; Lee, EC; Moller, T; Mussatto, CC; Ortiz, C; Rossetti, M; Tran, DH; Wang, J; Xu, C1
Araj, GF; Becker, SL; Berger, FK; Bischoff, M; Dbaibo, G; Gärtner, B; Karaoui, WR; Mahfouz, R; Matar, GM; Rasheed, SS; Rimmani, HH; Sharara, AI; von Müller, L1
Abe, K; Furukawa, K; Ishida, Y; Sakamoto, T; Shiba, H; Yanaga, K1
Dow, DE; Seed, PC1
Cammarota, G; Gasbarrini, A; Ianiro, G; Lopetuso, LR; Masucci, L; Quaranta, G; Sanguinetti, M; Simonelli, C1
Mullish, BH; Williams, HR1
Boulos, RA; Pagano, P; Pillar, CM; Shinabarger, DL; Wolfe, C1
Ip, M; Jiang, M; Leung, NH; You, JHS1
Kodadek, LM; Lipsett, PA1
Gandhi, S; Patel, D; Sohal, S1
Alireza Taghavi, S; Amanati, A; Bazargani, A; Heidari, H; Kalantar, K; Motamedifar, M; Nikokar, I; Sedigh Ebrahim-Saraie, H1
Ramesh, MS; Yee, J1
Fang, Z; Jiang, M; Liu, Y; Lv, X; Ren, W; Zhang, J1
Bauer, MP; Debast, SB; Kuijper, EJ; Sanders, IM; Wilcox, MH1
Bateman, BT; Bykov, K; Choudhry, NK; Fischer, MA; Franklin, JM; Gagne, JJ; Kulik, A; Liu, J; Polinski, JM; Rassen, JA; Schneeweiss, S1
Ahmad, S; Boothe, H; Cohen, HW; Coyle, C; Feinberg, EJ; Huh, HC; Kim, PK; Teperman, S1
Cotter, PD; Hill, C; Mathur, H; O'Connor, PM; Ross, RP1
Buppajarntham, S; Junpaparp, P; Madueno, FV; Varadi, G1
Neurath, MF; Strauss, R1
Cornely, OA; Fantin, B; Gorbach, S; Kean, Y; Miller, MA; Mullane, K1
Baji, P; Banai, J; Brodszky, V; Gulácsi, L; Kertész, A; Kopcsóné Németh, I; Ludwig, E; Péntek, M; Prinz, G; Reményi, P; Strbák, B; Zsoldiné Urbán, E2
Cornely, OA; Crook, DW; Golan, Y; Gorbach, SL; Josephson, MA; Louie, TJ; Miller, MA; Mullane, KM1
Bhatt, V; Parmar, SR; Schuster, M; Yang, J; Zhang, Q1
Clutter, DS; Dubrovskaya, Y; Merl, MY; Press, R; Safdar, A; Teperman, L1
Hung, YP; Ko, WC; Lee, CI; Lee, JC; Lin, HJ; Liu, HC; Tsai, PJ; Wan, L; Wu, TC; Wu, YH1
Kılıç, A1
de Vrieze, J1
Cui, E; Eells, SJ; Huang, SS; McKinnell, JA; Miller, LG1
Anttila, VJ; Arkkila, P; Mattila, E1
Ebigbo, A; Messmann, H1
Patel, LN; Schairer, J; Shen, B1
John, E; Lippmann, N; Lübbert, C; Mössner, J; Weis, S1
Causey, MW; Cummings, M; Johnson, EK; Maykel, JA; Steele, S; Walker, A1
Cornely, OA; Fantin, BR; Gorbach, SL; Kean, Y; Miller, MA; Mullane, KM1
Acharya, UH; Green, MR; Yeager, AM1
Cojocariu, C; Dorobat, C; Girleanu, I; Grigore, L; Sfarti, C; Singeap, AM; Stanciu, C; Trifan, A1
Chen, X; Enderlin, M; Fournier, E; Hubschwerlen, C; Keck, W; Kelly, CP; Klenk, A; Locher, HH; Pfaff, P; Ritz, D; Schroeder, S; Seiler, P1
García-Bujalance, S; Muñoz-Vélez, M1
Shafran, DM; Shafran, SD1
Farrell, MS; Marien, B; Schiowitz, MF1
Cioara, A; Filipescu, I; Flonta, M; Lupse, M; Todor, N1
Araki, K; Goto, H; Kikuchi, K; Koide, T; Makino, H; Ogawa, Y; Ohkuma, K; Saraya, T; Takizawa, H; Yonetani, S1
Enser, JJ; Hess, TM; Hsu, JL; Leverson, GE; McKown, T; Pirsch, JD; Safdar, N1
Kleger, A; Nitschmann, S; Seufferlein, T1
Wilcox, MH3
Smith, S1
Katzianer, DS; Rubin, H; Yano, T; Zhu, J1
Binion, DG; Hashash, JG1
Chen, X; Cheng, M; Hing, TC; Ho, S; Ichikawa, Y; Kelly, CP; Koon, HW; Pothoulakis, C1
Estes, L; Khanna, S; Pardi, D; Saffouri, G1
Sullivan, T1
Calvo-García, N; de Frutos-Serna, M; García-Sánchez, JE; Hernández-Egido, S; María-Blázquez, A; Siller-Ruiz, M1
Cornely, OA; Ivanescu, C; Nathwani, D; Odeyemi, IA; Odufowora-Sita, O; Retsa, P1
Alagoz, O; Codella, J; Heffernan, R; Safdar, N1
Balzola Regout, B; Ezpeleta Lobato, G; Loizaga Díaz, I; Vilella Ciriza, ML1
Adamson, WT; Erickson, KM; McLean, SE; Phillips, MR1
de Castro, CG; Ganc, AJ; Ganc, RL; Hamerschlack, N; Petrolli, MS1
Beamer, G; Kim, HB; Sun, X; Tzipori, S; Wang, Y; Zhang, Q1
Belyaev, O; Chromik, AM; Deleites, C; Herzog, T; Uhl, W1
Dees, A; Jonkman, JG; van Genderen, ME; van Rijn, M1
Bassis, CM; Schumacher, CA; Seekatz, AM; Theriot, CM; Young, VB1
Keller, JJ; Kuijper, EJ1
Christenson, ES; Hsu, S; Ligon, C1
Joundi, RA; Leis, JA; Wong, BM1
Bibbò, S; Cammarota, G; Costamagna, G; Dinoi, G; Gasbarrini, A; Ianiro, G; Masucci, L; Sanguinetti, M1
Biltaji, E; Kyle Jensen, M; LaFleur, J; Nelson, RE; Roberts, MS; Smith, KJ; Varier, RU1
Chiueh, TS; Huang, ZY; Lai, MJ; Lin, JC1
Liu, W; Lv, Z; Peng, G; Su, J; Xu, H1
Alm, E; Burgess, J; Burns, L; Didyk, E; Edelstein, C; Giovanelli, A; Kassam, Z; Mendolia, G; Noh, A; Smith, M; Stollman, N1
Barbut, F; Blais, L; Hirschel, B; Khanafer, N; Vanhems, P1
Ananthakrishnan, AN; Barber, GE; Wen, J1
Aldrete, Sdel M; Banks, GG; Burd, EM; Chan, AW; Friedman-Moraco, RJ; Kraft, CS; Magee, MJ1
Beardsley, JR; Johnson, JW; Luther, VP; Ohl, CA; Rokas, KE; Williamson, JC1
Demura, K; Imagawa, A; Kameyama, M; Kawasaki, M; Mizumura, N; Ogawa, M; Ohba, K; Okumura, S; Toyoda, S1
Marra, F; Ng, K1
Bellolio, F; Castillo, R; Manterola, C; Molina, ME; Quezada, F; Urrejola, G; Villalón, C; Zúñiga, JM1
Choudhry, SZ; Kashat, M; Lim, HW1
Forbes, BA; Gerding, DN; Goldstein, EJ; Jacobus, NV; Jenkins, SG; Johnson, S; McDermott, LA; Mirrett, S; Patel, R; Snydman, DR; Stone, S; Thorpe, C1
Greenberg, A; Matta, SK; Singh, A1
Delaune, A; Euler, CW; Fischetti, VA; Wang, Q1
Li, R; Lin, Y; Liu, X; Lu, L; Wang, M1
Clozel, M; Enderlin-Paput, M; Locher, HH; Pfaff, P; Ritz, D; Seiler, P; Weiss, M1
Ishimaru, T; Koga, T; Sawayama, Y; Takeda, R1
Abou Chakra, CN; Marcil-Héguy, A; Nault, V; Pépin, J; Sheitoyan-Pesant, C; Valiquette, L1
Housman, ST; Kuti, JL; Nicolau, DP; Quintiliani, R; Thabit, AK1
Marimuthu, K; Ochi, H; Young, BE1
Beardsley, JR; Gibbs, HG; Johnson, JW; Luther, VP; Ohl, CA; Rokas, KE; Williamson, JC1
Bernard, S; Block, BL; Schwartzstein, RM1
Chilton, CH; Crowther, GS; Ewin, D; Karas, A; Longshaw, C; Todhunter, SL; Vernon, J; Wilcox, MH1
Shah, KJ; Tarasiuk-Rusek, A1
Holroyd, KB; Pahwa, A; Rittenberg, A1
Brain, D; Connelly, LB; Graves, N; Merlo, G1
Baloun, B; Gilbert, J; Nelson, C; Wiedel, N1
del Mar Gamboa-Coronado, M; López-Ureña, D; Montoya-Ramírez, M; Quesada-Gómez, C; Rodríguez, C; Rodríguez-Cavallini, E; Somogyi, T1
Hill, E; Pressly, KB; Shah, KJ1
Beneš, J; Polívková, S1
Akamine, CM; Ing, MB; Jackson, CS; Loo, LK1
Telekes, A1
Winn, R; Zhu, KJ1
Dezsenyi, B; Fried, K; Gergely Szabo, B; Kadar, B; Kamotsay, K; Kunovszki, P; Nikolova, R; Prinz, G; Szidonia Lenart, K1
Stallmach, A1
Coburn, B; Guttman, DS; Hota, SS; Low, DE; McGeer, A; Poutanen, SM; Sales, V; Salpeter, MJ; Tomlinson, G1
Baro, E; Denies, F; Dervaux, B; Galperine, T; Guery, B; Lannoy, D; Lenne, X; Odou, P1
Hermsen, ED; Meza, JL; Njoku, JC; Olsen, KM; Qiu, F; Rupp, ME; Van Schooneveld, TC1
Banaei, N; Deresinski, S; Gombar, S; Holubar, M; Madison, A; Schroeder, LF; Shah, N; Shepard, J; Sundararajan, G; Tekic, N; Tompkins, L; Truong, CY; Wilson, R1
Evans, CT; Nelson, RL; Suda, KJ1
Estes, LL; Harmsen, WS; Nyre, LM; Orenstein, R; Patel, R; Schleck, CD; Verdoorn, BP; Wendt, RF; Wilson, JW1
Cima, RR; Selvasekar, CR; Yafi, FA1
Barker, HC; Bilton, D; Haworth, CS; Roberts, P; Williams, D1
Baines, SD; Freeman, J; O'Connor, R; Wilcox, MH1
Kaka, AS; Osawa, R1
Calfee, DP1
Baines, SD; Freeman, J; O'Connor, R; Saxton, K; Wilcox, MH1
Fujimoto, Y; Ishida, Y; Konishi, H; Kowata, S; Morimoto, Y; Nomura, K; Ohshiro, M; Oyake, T; Sato, K; Taniwaki, M; Yamashita, M; Yoshikawa, T1
Burman, LG1
Bartelsman, JF; Jansen, JM; Keller, JJ; Kuijper, EJ; Nieuwdorp, M; Speelman, P; van Heukelem, HA; van Nood, E; Visser, CE1
Cheknis, A; Chen, X; Gerding, DN; Goldsmith, JD; Katchar, K; Kelly, CP; Nanthakumar, N1
Prassler, R1
Kollef, MH; Shorr, AF; Zilberberg, MD1
Al-Nassir, WN; Donskey, CJ; Nerandzic, MM; Sethi, AK1
Dubberke, ER; Riddle, DJ2
Fitzpatrick, F1
Bressler, AM; Johnson, DP; Logan, N; Musher, DM; Rossignol, JF1
Bujanda, L; Cosme, A1
Kelly, CP2
Gould, FK; Hames, A; Perry, JD1
Bell, SJ; Critchley, IA; Hoang, T; Janjic, N; O'Leary, AL; Ochsner, UA; Stone, KC; Young, CL1
Altman, A; Paz, Z1
Johnson, S3
Shen, B; Wang, Y1
Chandok, N; Kamath, PS1
DePestel, DD; Frame, DG; Kaul, DR; Khaled, Y; Pogue, JM1
Gerding, DN; Hecht, DW; Johnson, S; Patel, T; Patel, U; Schriever, C1
Bakken, JS1
Bartlett, JG7
Ariyoshi, N; Harigaya, K; Hattori, N; Kitada, M; Miura, G; Nakamura, H; Nakasa, H; Oda, S; Sadahiro, T; Shinozaki, K; Toyoda, A; Yamagata, S; Yamazaki, S1
Scheppach, W1
Al-Nassir, WN; Bobulsky, GS; Donskey, CJ; Nerandzic, MM; Sethi, AK1
Causey, MW; Spencer, MP; Steele, SR1
Ambrosino, DM; Baxter, R; Blair, BM; Gerding, DN; Hay, CA; Leav, BA; Leney, M; Lowy, I; Molrine, DC; Nichol, G; Sloan, S; Thomas, WD1
Barbut, F; Eckert, C1
Nübel, U; Witte, W; Zaiss, NH1
Poxton, IR1
Chang, JH; Cho, HS; Cho, YK; Choi, MG; Chung, IS; Jung, WR; Kim, SW; Lee, YJ; Lim, CH; Nam, KW; Park, JM; Sung, HY1
Gagandeep, D; Ira, S1
Shaw, W1
Bernard, L; Grima, D; Miller, M; Pepin, J; Thompson, M1
Carroll, NV; Harpe, SE; Oinonen, M; Pakyz, AL; Polk, RE1
Iwasaka, T; Morimoto, S; Morita, T; Seo, M; Takahashi, N1
Simor, AE1
Jeong, JB; Jung, HC; Kim, BG; Kim, JS; Kim, JW; Lee, KL; Shin, S; Song, IS1
Hsueh, PR; Huang, YT; Ko, WC; Lee, NY1
Salkind, AR1
Antoniadou, A; Armaganidis, A; Dimopoulou, I; Kopterides, P; Papadomichelakis, E; Papageorgiou, C; Tsangaris, I1
Chihara, S; Furukata, S; Hoshino, K; Shimizu, R1
Hasuo, K; Hayashi, S; Hayashi, T; Jin, Y; Masuda, M; Rino, Y; Sawazaki, S; Suzuki, H; Tsuchida, K1
Al-Mufarrej, F; Gharagozloo, F; Margolis, M; Strother, E; Tempesta, B1
Gerding, DN; Johnson, S2
Ananthakrishnan, AN1
Chapnick, E; Kupfer, Y; Pagala, M; Rao, S; Tessler, S1
Dolgin, E1
Buckeridge, DL; Goldberg, P; Gursahaney, A; Hanley, J; Loo, V; Teltsch, DY1
Golan, Y; Gorbach, S; Lentnek, A; Louie, TJ; Miller, MA; Mullane, KM; Sears, P; Shue, YK; Weiss, K1
Studemeister, A1
Cohen, MB; Hart, KW; Lindsell, CJ; Mann, EA; Mezoff, E1
Alexander, J; Surawicz, CM1
Chang, S; Donskey, C; Dumford, DM; Nerandzic, M; Richmond, MA1
Amoros, F; Borrás-Blasco, J; Enriquez, R; Navarro-Ruiz, A; Padilla, S; Sirvent, AE; Solavera, J1
Chen, K; Davis, B; Feng, H; Sun, X; Wang, H; Zhang, Y1
Choi, HK; Kim, KH; Lee, SH; Lee, SJ1
Álvarez-Argüelles, H; Brito, ML; González-Brito, G; Hernández-Nieto, L; Lakhwani, S; Raya, JM1
Golan, Y; Gorbach, SL; Lentnek, A; Louie, TJ; Miller, MA; Mullane, KM; Sears, PS; Shue, YK; Weiss, K1
Babakhani, F; Citron, DM; Gerding, DN; Goldstein, EJ; Sambol, SP; Sears, P1
Alverdy, JC; Hall, DE; Neal, MD; Simmons, RL; Zuckerbraun, BS1
Callery, S; Daneman, N; Manek, K; Williams, V1
Amundson, WH; Decarolis, DD; Drekonja, DM; Johnson, JR; Kuskowski, MA; Lederle, FA1
Gardner, E; Mancuso, P; Meghani, N; Thomson, A1
Kang, JO; Kim, J; Pai, H; Seo, MR1
Deshpande, A; Minocha, A; Pant, C; Sferra, TJ1
Jahamy, H; Johnson, LB; Khatib, R; Patel, SM; Riederer, K; Shemes, SP; Szpunar, S; Valenti, S; Venugopal, AA1
Citron, DM; Goldstein, EJ; Merriam, CV; Tyrrell, KL1
Brown, NC; Dvoskin, S; Wright, GE; Xu, WC; Yanachkov, IB; Yanachkova, M1
Allerberger, F; Kuo, HW; Laferl, H; Michl, V; Schmid, D; Tesik, P; Tucek, G; Wenisch, C; Wenisch, JM1
Kee, VR1
Cornely, OA; Crook, DW; Esposito, R; Gorbach, S; Poirier, A; Sears, P; Somero, MS; Weiss, K1
Arora, V; Garey, KW; Le, F; Palmer, HR; Salazar, M; Shah, DN1
Aroniadis, OC; Brandt, LJ; Kanatzar, A; Kelly, C; Mellow, M; Park, T; Rohlke, F; Stollman, N; Surawicz, C1
Cadnum, JL; Donskey, CJ; Eckart, KE; Nerandzic, MM1
Armbruster, S; Goldkind, L1
Gerding, DN; Gorbach, SL; Johnson, S; Louie, TJ; Ruiz, NM1
Lamarche, MJ; Leeds, JA; McKenney, D; Praestgaard, J; Trzasko, A1
Bowlin, TL; Butler, MM; Citron, DM; Dvoskin, S; Feng, H; Kelly, CP; Shinabarger, DL; Tzipori, S; Wright, GE1
Bubenik, S; Heineman, J; Martindale, R; McClave, S1
Arya, A; Chuong, CL; Howland, KT; Kang, C; Li, T; Mascio, CT; Mortin, LI; Silverman, JA; Van Praagh, AD; Zhang, S1
Gerding, DN; Monnot-Chase, E; Seiberling, M; Tatarowicz, W; Villano, SA1
Aoki, T; Fujiwara, M; Fukuzawa, M; Harada, A; Hayama, Y; Kataoka, M; Kawai, T; Kawakami, K; Moriyasu, F; Naitou, S; Nonaka, M; Sou, Y; Sugimoto, H; Takeuchi, M; Tsuji, Y; Yagi, K; Yamamoto, K1
Barman, TK; Bhati, A; Bhatnagar, PK; Chakrabarti, A; Das, B; Kalia, V; Kumar, M; Mathur, T; Pandya, M; Raj, VS; Ramkumar, G; Shukla, G; Upadhyay, DJ; Vaishnavi, C1
Carchman, EH; Nassour, I; Simmons, RL; Zuckerbraun, BS1
Kim, SW1
Bossé, D; Cantin, AM; Lemire, C; Ménard, F; Ruel, J; Valiquette, L1
Anttila, VJ; Arkkila, P; Mattila, E; Mattila, PS; Tarkka, E; Tissari, P1
Ha, D; Tsai, CJ1
Brandt, C; Clare, S; Clark, TG; Connor, TR; Deakin, LJ; Dougan, G; Duncan, SH; Flint, HJ; Goulding, D; Lawley, TD; Parkhill, J; Pickard, DJ; Rad, R; Raisen, C; Schreiber, F; Stares, MD; Walker, AW1
Bonomo, RA; Donskey, CJ; Drawz, PE; Hirsch, AA; Jump, RL; Jury, LA; Kypriotakis, G; Olds, DM; Peron, EP; Seifi, N; Watts, B1
Guerrant, RL; Hoffman, PS; Kolling, GL; Li, Y; Moore, JH; Riggins, MS; van Opstal, EJ; Warren, CA1
Mehta, J; Pi, J; Trifilio, SM1
Arzese, A; Bassetti, M; Pecori, D; Villa, G; Wilcox, M1
Elmer, GW; McFarland, LV; Surawicz, CM1
Apisarnthanarak, A; Mundy, LM; Razavi, B1
Alcázar Montero, MS; Gimeno Aranguez, M; Navarro Gaspar, C; Vilalta Castel, E1
Lenzen-Grossimlinghaus, R; Strohmeyer, G1
Chang, KH; Chong, Y; Kim, JM; Kim, MS; Lee, K; Shin, JW; Yong, D1
Tanaka, K; Watanabe, K1
Akishita, M; Mizukawa, S; Ohni, M; Sudoh, N; Sugiyama, Y; Toba, K1
Cirocco, WC1
Martirosian, G; Szczesny, A1
Goldsmith, EA; Marino, BJ; Musher, DM; Wanahita, A1
Glinka, D; Meisel-Mikołajczyk, F; Obuch-Woszczatyński, P; Pituch, H; Łazińska, B; Łuczak, M1
Chu, C; Greenberg, DP; Hussain, SZ; Khan, S; Orenstein, D1
Bartoloni, A; Benedetti, M; Dei, R; Goldstein, BP; Mantella, A; Paradisi, F; Sbaragli, S1
Basu, A; Fung, JJ; Keven, K; Marcos, A; Re, L; Shapiro, R; Simmons, RL; Starzl, TE; Tan, H1
Adachi, G; Akutagawa, H; Edagawa, G; Egashira, Y; Hirata, I; Katsu, K; Kurisu, Y; Shibayama, Y; Takada, K1
Anton, PM; Eisenstein, B; Kelly, CP; Kokkotou, E; Michaelis, A; O'Brien, M; Paraschos, S; Pothoulakis, C; Rothstein, D1
Ravid, M1
Furui, J; Haraguchi, M; Kanematsu, T; Komuta, K1
Oldfield, EC1
Schroeder, MS1
Surawicz, CM1
Brazier, J; Burmeister, S; Lewis, S1
Aslam, S; Bhaila, I; Borchert, F; Hamill, RJ; Logan, N; Musher, DM; Nallacheru, S1
Gerding, DN3
Alary, ME; Bourassa, C; Fulop, K; Godin, D; Pepin, J; Raiche, E; Ruel, J; Valiquette, L1
Alonso, R; Bouza, E; Muñoz, P1
Hayakawa, T; Hibi, T; Imaeda, H; Ishii, H; Iwao, Y; Komoto, S; Maruta, K; Nakamura, M; Ogata, H; Shiozu, H1
Aslam, S; Hamill, RJ; Musher, DM1
Starr, J1
Baines, SD; Freeman, J; Jabes, D; Wilcox, MH1
Bac, DJ; Dingemans-Dumas, AM; Visser, WE1
Arango, JI; Bradshaw, P; Callander, NS; Freytes, CO; Ochoa-Bayona, JL; Patterson, J; Restrepo, A; Restrepo, MI; Schneider, DL1
Daum, RS; Glikman, D; Kahanna, M; Vora, S1
Jakobsen, L; Tvede, M1
Alpert, MA; Aradhyula, S; Bhutto, SS; Hafidh, SA; Manian, FA1
Cadle, RM; Darouiche, RO; Mansouri, MD1
Høiby, N; Tvede, M1
Chasan-Taber, S; Davidson, DM; Dow, G; Garber, G; John, JF; Johnson, D; Louie, TJ; Mohammed, R; Peppe, J; Simon, S; Watt, CK; Weiss, K1
Delaney, JA; Dial, S; Schneider, V; Suissa, S1
Cunningham, R1
Beyer, I; Byl, B; Cherifi, S; Delmee, M; Mascart, G; Van Broeck, J1
Cicogna, CE; Kuyumjian, AG; Surowiec, D; Wynd, MA1
Heins, JR1
Alcides, AP; Avelar, KE; Balassiano, IT; Boente, RF; Brazier, JS; de Paula, GR; Domingues, RM; Ferreira, EO; Ferreira, MC; Miranda, KR; Pinto, LJ1
Dohi, Y; Kimura, Y; Mizokami, M; Nakamura, N; Orito, E; Sato, K; Tokuda, H1
Galang, M; Gerding, DN; Johnson, S; Kelly, CP; Schriever, C1
Hornillos Calvo, M; Pareja Sierra, T1
Bakkanagari, SR; Davis, MB; Moorthi, KM; Zar, FA1
Hassoun, A; Ibrahim, F1
Nelson, R1
Pakyz, A1
Koh, TH; Song, KP; Tan, AL; Tan, ML; Wang, G1
Brazeau, I; Gagnon, S; Pépin, J; Routhier, S; Valiquette, L1
Shen, EP; Surawicz, CM1
Mladenova, I; Pekova, L; Pellicano, R; Shomov, G1
Hooker, M1
Gerding, DN; Muto, CA; Owens, RC1
Halsey, J1
Pepin, J1
Al-Nassir, WN; Donskey, CJ; Li, Y; Pultz, MJ; Riggs, MM; Sethi, AK1
Kuipers, EJ; Surawicz, CM1
Carter, JE; Mizell, KN1
Kuijper, EJ; Wilcox, MH1
Al-Nassir, WN; Bobulsky, GS; Donskey, CJ; Jump, RL; Nerandzic, MM; Sethi, AK1
Gugler, R; Steudel, HC1
Dyson, PH; Schapira, AH1
Bolton, RP1
Batts, DH; Fekety, R; Green, EG; Hamilton, JP; Schwartz, JN; Silva, J; Stamper, L1
Lamont, JT; Trnka, YM1
Arbogast, JG; Liebig, CW; Ponte, CD1
Burdon, DW2
Drapkin, MS1
McDonald, AJ; Milstone, EB; Scholhamer, CF1
Buggy, B; Deery, HG; Fekety, R; Silva, J1
Acikalin, T; Smith, J1
Lofgren, RP; Soltis, RD; Tadlock, LM1
Pfitzner, U1
Baer, M; Grönroos, P; Mäki, M; Vesikari, T1
Eliopoulos, GM; Spitzer, PG1
Mehta, JB; Thomas, E1
Burdon, DW; Hawker, PC; Hine, KR; Keighley, MR; Thompson, H1
Borriello, SP; Glazer, G; Phillips, RK1
Brown, JR1
Brown, R; Wise, R1
Wu, A1
Gilligan, PH; Long, SS; Prebis, JW; Thompson, CM1
Brabyn, DG; Chance, GW; Han, VK; Sayed, H; Shaheed, WA1
Blake, M; Koornhof, HJ; Miliotis, M; Miller, SD; Still, C; Taubin, A1
Tedesco, FJ5
Accardo, P; Bortone, AM; D'Imperio, N; Dal Monte, PR; Formica, G; Giuliani-Piccari, G; Simoni, S1
Loeschke, K1
Arabi, Y; Bentley, S; Burdon, DW; Johnson, M; Keighley, MR; Mogg, GA; Youngs, D1
Herlihy, KJ; Powell, DW; Saco, LS1
Fahrländer, H1
Keighley, MR2
Bartlett, JG; Chang, T; Lowe, B; Shull, S; Tedesco, FJ1
Cherry, RD; Daly, DS; Goresky, CA; Jabbari, M; Kinnear, DG; Portnoy, D1
Chevrel, B1
Eglinton, GS; Mayes, GR; Potts, DW1
Lamont, JT; Levine, HG1
Finegold, SM; George, WL; Harding, GK; Klein, R; Putnam, CW; Rolfe, RD1
Meuwissen, SG; Mulder, CJ; Reiss, M; Rietra, PJ; Van Leeuwen, AM; Visser, J1
Pennington, CR; Ritchie, PH1
Beesley, J; Eastham, EJ; Jackson, RH; Nelson, R1
Rampling, A; Swayne, RL; Warren, RE1
Fekety, R; Kim, KH; Silva, J; Toshniwal, R1
Bartlett, JG; Moskovitz, M1
Bartlett, JG; Viscidi, RP1
Murray, D; Portnoy, D; Richards, GK; Soneji, A1
Freeman, HJ; Owen, D; Rabeneck, L1
Berman, MM; Helgason, H; Hyams, JS1
Bartlett, JG; Taylor, NS1
Oliver, PR1
Bartlett, JG; Chang, TW; Gorbach, SL; Saginur, R1
Bartlett, JG; Mendelow, H; Wald, A1
Moore, B; Philpot, CR; Rich, G; Wilkinson, IJ1
Finegold, SM; George, WL; Rolfe, RD1
Friedman, RJ; Galambos, JT; Hersh, T; Mayer, IE1
Bowman, RA; Riley, TV1
Roberts, RK; Seneviratne, E1
Rampling, A; Sykes, HV; Warren, RE1
Barats, JC; Haegy, JM; Laplatte, G1
Batts, DH; Browne, RA; Cudmore, MA; Fekety, R; Kim, KH; Silva, J; Toshniwal, R; Wilson, KH1
Bartlett, JG; Chang, T; Dzink, J; Taylor, NS1
Eriksson, S1
Malchow-Møller, A; Matzen, P1
Cox, JN; Eisenhoffer, N; Nusslé, D1
Miller, JA; Oldenburger, D1
Levine, M; Ling, EW; McDougal, A1
Pote, HH; Schenfeld, LA1
Chan, SM; Chia, JK; Goldstein, H1
Armstrong, CJ; Wilson, TS1
Benfiguig, K; Eugène, C; Merrer, J; Mitry, E; Tordjman, R1
Kubo, M; Satoh, T; Wada, Y1
Fraser, GM; Inbar-Yanai, I; Niv, Y1
Gerding, DN; Lee, JT; Olson, MM; Shanholtzer, CJ1
Barton, TL; Bublin, JG1
Demling, L; Stoll, R1
Deveney, CW; Deveney, KE; Grasley, A; Jobe, BA; Sheppard, BC1
Messick, CR; Reinke, CM1
Bacon, AE; Caputo, GM; Weitekamp, MR; Whitener, C1
Dean, PC; Farquhar, DS; Gremse, DA1
Brandt, LJ; Lu, SS; Schwartz, JM; Simon, DM1
Hoppen, T; Keller, KM; Rister, M; Stolte, M1
Carrel, T; Mihaljevic, T; Opravil, M; Pasic, M; Turina, M; von Segesser, L1
Berman, DS; Wenglin, BD1
Avicolli, AS; Goldman, WM; Lutwick, S1
Jacobs, NF1
Beattie, TJ; Burgner, DP; Rfidah, H; Seal, DV1
Carrel, T; Jost, R; Pasic, M; Turina, M; Von Segesser, L1
Clark, KH; Haley, T; Jernigan, TW1
Cappell, MS; Philogene, C1
Borucki, MJ; Clench, MH; Cozart, JC; Kalangi, SS; Pollard, RB; Soloway, RD; Taylor, DR1
Rexroth, G1
Dever, LL; Eng, RH; Handwerger, S; Smith, SM1
Johnson, TR; Pitt, HA; Sciscione, AC; Villeneuve, JB1
Alexander, F; Grundfest-Broniatowski, S; Lavery, I; Milsom, J; Quader, M; Walsh, RM1
Schweitzer, MA; Silver, DL; Stellato, TA; Sweiss, I1
Linscheid, RL; O'Duffy, JD; Wright, TW1
Graninger, W; Hasenhündl, M; Hirschl, AM; Parschalk, B; Wenisch, C1
Fujita, K; Kato, H; Kato, N; Sakata, Y; Ueno, K; Watanabe, K1
Dare, A; Lapiński, TW1
Golden, WE; Pitts, B; Sanchez, N1
Davis, JM; Hong, J1
Kurita, S; Nagatake, T; Ohishi, K; Rikitomi, N; Sato, A; Uchida, R; Watanabe, H1
Mack, D; Nierhaus, A; Pollok, JM; Pothmann, W; Schäfer, P1
Brewrink, J; Cross, AS; McCarter, RJ; Morris, JG; Roghmann, MC1
Kelly, CP; LaMont, JT1
Hazir, T; Jan, IA; Khan, MA; Khan, NA; Qazi, A1
Kavan, P; Koutecky, J; Lochmann, O; McClain, LK; Nyc, O; Skala, PJ; Sochor, M1
Hager, K; Ruwe, A1
Brooks, S; Friedeman, L; Griffith, J; Hameed, R; Khan, A; Mukherji, R; Schupf, N; Stoica, D1
Corpuz, M; Nair, S; Pitchumoni, CS; Yadav, D1
Calişkaner, Z; Koçar, IH; Pay, S; Turan, M1
Elmer, GW; Fekety, R; Greenberg, RN; McFarland, LV; Rubin, M; Surawicz, CM1
Hoshika, K1
Luk, WK; Wong, SS; Woo, PC; Yuen, KY1
Byrne, P; Fekety, R; Joseph, R; Miller, JM; Silva, J1
Campbell, I; Shedda, S; Skinner, I1
Bianchi, L; Furlanut, M; Pea, F1
McVay, CS; Rolfe, RD1
Alcantara, CS; Guerrant, RL1
Borjal, D; Bowen, K; Brandmarker, S; Elmer, GW; Fekety, R; Garcia, RJ; Greenberg, RN; McFarland, LV; Mulligan, ME; Rubin, M; Surawicz, CM1
Ballmer, PE; Bergamin, B; Hess, T; Imoberdorf, R; Jost, R1
Jones, RL1
Calderwood, SB; Mylonakis, E; Ryan, ET1
Kelly, CP; Kyne, L1
Kerst, JM; Kuijper, EJ; van der Lelie, J1
Bouza, E; Muñòz, P; Palomo, J; Yáñèz, J1
Nieuwenhuis, R; Shetler, K; Triadafilopoulos, G; Wren, SM1
Chao, L; Nathanson, DR; Sheahan, M; Wallack, MK1
Handke, R; Schmitt-Grohé, S; Steffan, J; Wiggert, E; Zielen, S1
Apisarnthanarak, A; Crippin, JS; Khoury, H; Mundy, LM; Reinus, WR1
Kański, A; Martirosian, G; Szczesny, A1
Alcalá, L; Alonso, R; Bouza, E; García-Lechuz, JM; Peláez, T; Rodríguez-Créixems, M1
Siristonpun, Y; Tanphaichitra, D1
Esposito, AL; Gleckman, RA1
Delchier, JC; Modigliani, R1
Borriello, SP; Larson, HE; Levi, AJ1
Bartlett, JG; Christie, D; Gurwith, M; Markham, R; Tedesco, F1
Burdon, DW; George, RH; Johnson, EM; Youngs, DJ1
Finch, RG; George, RH; Lewis, MJ; Slack, RC; Thomas, HJ1
Del Favero, A; Menichetti, F; Morelli, A; Narducci, F; Pelli, MA1
Bartlett, JG; Chang, TW; Onderdonk, AB1
Bartlett, JG; Chang, TW; Gamble, W; Napier, J; Tedesco, FJ1
Cook, FV; Farrar, WE1
Arabi, Y; Bentley, S; Burdon, DW; George, RH; Johnson, M; Keighley, MR; Mogg, GA; Thompson, H; Williams, JA; Youngs, D1
Saffouri, B1
Finegold, SM; George, WL; Liechty, EJ; Mok, HY; Richman, DD; Rolfe, RD; Stiner, DB; Volpicelli, NA1
Crow, J; Larson, HE; Price, AB1
Alexander-Williams, J; Arabi, Y; Brown, JD; Burdon, DW; George, RH; Keighley, MR; Shinagawa, N; Youngs, DJ1
Werner, H1
Alexander-Williams, J; Bentley, S; Burdon, DW; George, RH; Johnson, M; Keighley, MR; Mogg, GA; Youngs, D1
Esaki, PE; Saadah, HA1
Kerrihard, GN1
Broitman, SA; Katz, L; LaMont, JT; Rieth, S; Rothman, SW; Sonnenblick, EB; Trier, JS1
Long, CI; Vannatta, JB1
Badley, BW; Comeau, SA; Faulkner, RS; Hartlen, MR; Marrie, TJ; Miller, HR1
Brun-Buisson, C; Chapman, A; Himmich, H; Voinchet, O1
Browne, RA; Ebright, JR; Fekety, R; Rifkin, GD; Silva, J1
Bartlett, JG; Cisneros, RL; Onderdonk, AB1
Abrams, GD; Boyd, DI; Browne, RA; Fekety, R; Silva, J; Work, CO1
Ledger, WJ; Puttler, OL1
Bettin, KM; Clabots, CR; Gerding, DN; Homann, SR; Johnson, S; Peterson, LR; Quick, JN1
Spencer, RC; Wilcox, MH1
Bagwell, CE; Langham, MR; Mahaffey, SM; Shandling, B; Talbert, JL1
McGurrey, E1
Barkin, JS; Gregg, PA; Kershenobich, D; Lubin, J; Wiesen, S1
de Lalla, F; Manfrin, V; Nicolin, R; Rigoli, R; Rinaldi, E; Scarpellini, P; Tramarin, A1
Langdale, V; Levene, M; MacKay, P; Martin, C; Millar, MR1
Chen, C1
Arning, M; Aul, C; Chlebowski, H; Gehrt, A; Hadding, U; Schneider, W; Wolf, M1
Dru, M1
Dielman, DG; McCullough, JM; Peery, D1
Changchien, CS; Chen, PC; Chiu, CT; Chuah, SK; Lin, HH; Wu, CS1
Ariano, RE; Harding, GK; Zhanel, GG1
Ebina, K; Hirano, T; Ohi, H; Sugawara, A1
Aprahamian, C; Bergstein, JM; Kramer, A; Quebbeman, EJ; Wittman, DH1
Montes de Oca, G; Oh, T; Osorno, RJ1
Wheeler, WE; Yarinsky, S1
Cerf, M; Levecq, H1
Barile, C; Conforti, M; Merlo, M; Violato, F1
Guglielmo, BJ; Jacobs, R; Oliva, SL; Pons, VG1
Chamovitz, BN; McKenna, JP1
Chinn, J; Elmer, G; McFarland, LV; Surawicz, CM1
Silva, J1
Ritchie, M1
Chang, TW; Dong, MY; Gorbach, SL1
Lindmark, A; Nord, CE; Persson, I1
Gupta, R; Sachar, DB1
Hecht, JR; Olinger, EJ1
Cardines, R; Gianfrilli, P; Luzzi, I; Pantosti, A1
Chen, DC; Chen, MJ; Chen, YF; Ma, S; Tang, WS; Xie, XL1
Filston, HC; Friedman, HS; Gutman, LT; Rourk, MH; Shorter, NA; Ware, R1
Dear, PR; Ng, PC; Thomas, DF1
Hausmann, L; Tacke, W1
Avesani, V; Delmée, M; Michaux, JL; Vandercam, B1
Bingley, PJ; Harding, GM1
Roda, PI1
Cattau, EL; Van Ness, MM1
Bick, RJ; Haaga, JR; Zollinger, RM1
Miller, SN; Ringler, RP1
Elmer, GW; McFarland, LV1
Barclay, F; Bonnycastle, M; Borriello, SP; Piper, M; Seal, D; Welch, A1
Goh, KL; Peh, SC; Wong, NW1
Fussell, S; Ginter, GL; Olsen, E; Pendray, M; Scheifele, DW1
Dolan, PJ; Goodpasture, HC; Jacobs, ER; Meredith, WT1
Beart, RW; Talbot, RW; Walker, RC1
Brownlee, K; Dear, P; Tulloh, R1
Bogokowsky, B; Chagnac, A; Lurie, B1
Church, JM; Fazio, VW1
Arsura, EL; Fazio, RA; Wickremesinghe, PC1
Amin, NM1
Balmaseda, MT; Johnson, DK1
Adams, GL; Griebie, M1
Bayley, N; Gordon, D; Hecker, R; Higgins, G; Labrooy, J; McDonald, MI; Trapani, JA; Ward, PB; Young, GP1
Barzilai, A; Eitan, A; Erlich, N; Toledano, C1
Fortson, WC; Gordon, D; Tedesco, FJ1
Anderson, GD; McNeeley, SG; Sibai, BM1
Henderson, IS; Leung, AC; McLay, A; Orange, G1
Li, ZJ; Liu, LX; Niu, HZ; Song, HY; Zhang, XY1
Riley, HD1
Hall, WH; Khan, MY2

Reviews

103 review(s) available for vancomycin and Antibiotic-Associated Colitis

ArticleYear
Real-world comparison of fidaxomicin versus vancomycin or metronidazole in the treatment of Clostridium difficile infection: a systematic review and meta-analysis.
    European journal of clinical pharmacology, 2022, Volume: 78, Issue:11

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Vancomycin

2022
Evolving Strategies to Manage Clostridium difficile Colitis.
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2020, Volume: 24, Issue:2

    Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Bacterial Toxins; Broadly Neutralizing Antibodies; Clostridioides difficile; Colectomy; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Humans; Ileostomy; Risk Factors; Therapeutic Irrigation; Vancomycin

2020
Faecal microbiota transplantation for Clostridium difficile-associated diarrhoea: a systematic review of randomised controlled trials.
    The Medical journal of Australia, 2017, Aug-21, Volume: 207, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Feces; Humans; Randomized Controlled Trials as Topic; Vancomycin

2017
    Clinical medicine (London, England), 2018, Volume: 18, Issue:3

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Humans; Metronidazole; Probiotics; Vancomycin

2018
Prevention and Treatment of Clostridium difficile Enterocolitis.
    Advances in surgery, 2018, Volume: 52, Issue:1

    Topics: Clostridioides difficile; Colectomy; Cross Infection; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Incidence; Male; Metronidazole; Risk Assessment; Severity of Illness Index; United States; Vancomycin

2018
Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease.
    Advances in chronic kidney disease, 2019, Volume: 26, Issue:1

    Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antimicrobial Stewardship; Broadly Neutralizing Antibodies; Clostridium Infections; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Hand Hygiene; Health Care Costs; Humans; Infection Control; Kidney Failure, Chronic; Length of Stay; Metronidazole; Patient Isolation; Renal Insufficiency, Chronic; Secondary Prevention; Vancomycin

2019
[Antimicrobial therapy of Clostridium difficile infection. Systematic review and meta-analysis of the scientific evidence].
    Orvosi hetilap, 2013, Jun-09, Volume: 154, Issue:23

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Treatment Outcome; Vancomycin

2013
[Clostridium difficile infection: epidemiology, disease burden and therapy].
    Orvosi hetilap, 2013, Jul-28, Volume: 154, Issue:30

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cost of Illness; Cross Infection; Diarrhea; Drug Costs; Enterocolitis, Pseudomembranous; Health Care Costs; Humans; Hungary; Metronidazole; Public Health; Recurrence; Seasons; Vancomycin

2013
[Clostridium difficile infection: epidemiology, risk factors, pathogenesis, clinical features, diagnosis and therapy].
    Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Humans; Metronidazole; Risk Factors; Vancomycin; Virulence

2013
A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission.
    Infection control and hospital epidemiology, 2013, Volume: 34, Issue:10

    Topics: Carrier State; Clostridioides difficile; Diabetes Mellitus; Drug Resistance, Bacterial; Enterococcus; Enterocolitis, Pseudomembranous; Heart Failure; Humans; Immunosuppression Therapy; Intensive Care Units; Lung Diseases; Methicillin-Resistant Staphylococcus aureus; Nursing Homes; Patient Admission; Renal Insufficiency; Risk Factors; Staphylococcal Infections; Vancomycin

2013
[Fecal transfusion as treatment of Clostridium difficile infection].
    Duodecim; laaketieteellinen aikakauskirja, 2013, Volume: 129, Issue:16

    Topics: Anti-Infective Agents; Enterocolitis, Pseudomembranous; Feces; Finland; Humans; Intubation, Gastrointestinal; Metronidazole; Therapeutic Irrigation; Vancomycin

2013
Treating Clostridium difficile infection.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2014, Apr-15, Volume: 186, Issue:7

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Vaccines; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Probiotics; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin

2014
Methicillin-resistant Staphylococcus aureus enterocolitis sequentially complicated with septic arthritis: a case report and review of the literature.
    BMC research notes, 2014, Jan-09, Volume: 7

    Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Bacteremia; Bacterial Typing Techniques; Catheter-Related Infections; Catheters; Clone Cells; Community-Acquired Infections; Cross Infection; Diabetes Mellitus, Type 2; Diagnosis, Differential; Disease Susceptibility; Enterocolitis; Enterocolitis, Pseudomembranous; Equipment Contamination; Evolution, Molecular; Feces; Hip Joint; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Pneumococcal; Shock, Septic; Staphylococcal Infections; Synovial Fluid; Vancomycin

2014
Managing Clostridium difficile in inflammatory bowel disease (IBD).
    Current gastroenterology reports, 2014, Volume: 16, Issue:7

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Humans; Inflammatory Bowel Diseases; Opportunistic Infections; Tissue Transplantation; Vancomycin

2014
Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:11

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Treatment Outcome; Vancomycin

2014
Treatment of recurrent and severe Clostridium difficile infection.
    Annual review of medicine, 2015, Volume: 66

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Humans; Metronidazole; Microbiota; Recurrence; Severity of Illness Index; Transplantation; Vancomycin

2015
Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection.
    Drugs, 2015, Volume: 75, Issue:10

    Topics: Aminoglycosides; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Humans; Incidence; Metronidazole; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Probiotics; Recurrence; Risk Factors; Vancomycin

2015
Efficacy and Safety of Metronidazole Monotherapy versus Vancomycin Monotherapy or Combination Therapy in Patients with Clostridium difficile Infection: A Systematic Review and Meta-Analysis.
    PloS one, 2015, Volume: 10, Issue:10

    Topics: Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin

2015
[Oncologic aspects of Clostridium difficile].
    Orvosi hetilap, 2016, Volume: 157, Issue:28

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Gastrointestinal Microbiome; Humans; Recurrence; Risk Factors; Vancomycin

2016
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.
    The Cochrane database of systematic reviews, 2017, 03-03, Volume: 3

    Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacitracin; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Randomized Controlled Trials as Topic; Teicoplanin; Treatment Outcome; Vancomycin

2017
Maculopapular rash induced by oral vancomycin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Sep-15, Volume: 47, Issue:6

    Topics: Administration, Oral; Aged; Enterocolitis, Pseudomembranous; Exanthema; Female; Humans; Vancomycin

2008
Clostridium difficile: a reemerging pathogen.
    Geriatrics, 2008, Sep-01, Volume: 63, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Communicable Diseases, Emerging; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Incidence; Infection Control; Metronidazole; Risk Factors; Vancomycin

2008
Clostridium difficile infection in solid organ transplant recipients.
    Current opinion in organ transplantation, 2008, Volume: 13, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Digestive System Surgical Procedures; Enterocolitis, Pseudomembranous; Humans; Incidence; Infection Control; Metronidazole; Organ Transplantation; Risk Factors; Severity of Illness Index; Treatment Outcome; Vancomycin; Virulence

2008
[Clostridium-difficile-associated diarrhea].
    Gastroenterologia y hepatologia, 2009, Volume: 32, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Biological Therapy; Clostridioides difficile; Colectomy; Colonoscopy; Combined Modality Therapy; Cross Infection; Diarrhea; DNA, Bacterial; Enterocolitis, Pseudomembranous; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Infant, Newborn; Male; Metronidazole; Probiotics; Recurrence; Risk Factors; Superinfection; Vancomycin

2009
A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection.
    JAMA, 2009, Mar-04, Volume: 301, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Intestines; Male; Metronidazole; Probiotics; Recurrence; Risk Factors; Severity of Illness Index; Vancomycin

2009
Recurrent Clostridium difficile infection: causality and therapeutic approaches.
    International journal of antimicrobial agents, 2009, Volume: 33 Suppl 1

    Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Immunotherapy; Metronidazole; Probiotics; Randomized Controlled Trials as Topic; Secondary Prevention; Vancomycin

2009
Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
    The Journal of infection, 2009, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Risk Factors; Treatment Outcome; Vancomycin

2009
Clostridium difficile infection in the intensive care unit.
    Infectious disease clinics of North America, 2009, Volume: 23, Issue:3

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Incidence; Intensive Care Units; Metronidazole; Vancomycin

2009
[Infections with Clostridium difficile following antibiotic therapy].
    MMW Fortschritte der Medizin, 2009, Oct-01, Volume: 151, Issue:40

    Topics: Administration, Oral; Algorithms; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Endoscopy; Enterocolitis, Pseudomembranous; Hand Disinfection; Humans; Metronidazole; Recurrence; Time Factors; Vancomycin

2009
Clostridium difficile enteritis after colectomy.
    The American surgeon, 2009, Volume: 75, Issue:12

    Topics: Adult; Anti-Bacterial Agents; Colectomy; Enterocolitis, Pseudomembranous; Female; Humans; Ileostomy; Male; Metronidazole; Middle Aged; Vancomycin

2009
[Clostridium-difficile-associated infections].
    Medecine sciences : M/S, 2010, Volume: 26, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Base Sequence; Clostridioides difficile; Combined Modality Therapy; Disease Outbreaks; Enterocolitis, Pseudomembranous; Enterotoxins; Europe; Fluid Therapy; Humans; Incidence; Metronidazole; Molecular Sequence Data; North America; Ribotyping; Vancomycin; Virulence

2010
Fidaxomicin: a new macrocyclic, RNA polymerase-inhibiting antibiotic for the treatment of Clostridium difficile infections.
    Future microbiology, 2010, Volume: 5, Issue:4

    Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Clinical Trials as Topic; Clostridioides difficile; Cross Infection; DNA-Directed RNA Polymerases; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Secondary Prevention; Treatment Outcome; Vancomycin

2010
Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review.
    Journal of the American Geriatrics Society, 2010, Volume: 58, Issue:8

    Topics: Aged; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Equipment Contamination; Humans; Infection Control; Long-Term Care; Metronidazole; Risk Factors; Severity of Illness Index; Vancomycin

2010
Clostridium difficile bacteremia, Taiwan.
    Emerging infectious diseases, 2010, Volume: 16, Issue:8

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Child; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Taiwan; Vancomycin; Young Adult

2010
Clostridium difficile: an update for the primary care clinician.
    Southern medical journal, 2010, Volume: 103, Issue:9

    Topics: Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Hand Disinfection; Humans; Metronidazole; Patient Isolation; Primary Health Care; Probiotics; Recurrence; Severity of Illness Index; Vancomycin

2010
Post-esophagectomy pseudomembranous inflammation of the interposed colon.
    Surgical infections, 2010, Volume: 11, Issue:5

    Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Colon; Enterocolitis, Pseudomembranous; Esophagectomy; Humans; Male; Middle Aged; Postoperative Complications; Vancomycin

2010
Management of Clostridium difficile infection: thinking inside and outside the box.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Dec-01, Volume: 51, Issue:11

    Topics: Aminoglycosides; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antitoxins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Vaccination; Vancomycin

2010
Clostridium difficile infection: epidemiology, risk factors and management.
    Nature reviews. Gastroenterology & hepatology, 2011, Volume: 8, Issue:1

    Topics: Clostridioides difficile; Colitis; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Prevalence; Risk Factors; Vancomycin

2011
Clostridium difficile: progress and challenges.
    Annals of the New York Academy of Sciences, 2010, Volume: 1213

    Topics: Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Humans; Metronidazole; Polymerase Chain Reaction; Practice Guidelines as Topic; Vancomycin

2010
Treatment of refractory and recurrent Clostridium difficile infection.
    Nature reviews. Gastroenterology & hepatology, 2011, Volume: 8, Issue:6

    Topics: Clostridioides difficile; Colectomy; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Severity of Illness Index; Treatment Outcome; Vancomycin

2011
Clinical approach to severe Clostridium difficile infection: update for the hospital practitioner.
    European journal of internal medicine, 2011, Volume: 22, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Hospitalists; Humans; Incidence; Internal Medicine; Metronidazole; Severity of Illness Index; Vancomycin

2011
Clostridium difficile infection in older adults: a review and update on its management.
    The American journal of geriatric pharmacotherapy, 2012, Volume: 10, Issue:1

    Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Infection Control; Metronidazole; Risk Factors; Vancomycin

2012
Meeting the challenge of recurrent Clostridium difficile infection.
    Journal of hospital medicine, 2012, Volume: 7 Suppl 3

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Humans; Hygiene; Metronidazole; Risk Factors; Secondary Prevention; Severity of Illness Index; Vancomycin

2012
Current strategies for management of initial Clostridium difficile infection.
    Journal of hospital medicine, 2012, Volume: 7 Suppl 3

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Intestines; Length of Stay; Metronidazole; Recurrence; Rehabilitation Centers; Risk Factors; Severity of Illness Index; Vancomycin

2012
Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases?
    Current gastroenterology reports, 2012, Volume: 14, Issue:4

    Topics: Bacterial Infections; Drug Resistance, Bacterial; Enterococcus; Enterocolitis, Necrotizing; Enterocolitis, Pseudomembranous; Helicobacter Infections; Helicobacter pylori; Humans; Pneumonia, Ventilator-Associated; Probiotics; Vancomycin

2012
Novel management strategies in the treatment of severe Clostridium difficile infection.
    Advances in surgery, 2012, Volume: 46

    Topics: Algorithms; Anti-Infective Agents; Colectomy; Enterocolitis, Pseudomembranous; Humans; Ileostomy; Immunization; Metronidazole; Prognosis; Recurrence; Risk Factors; Vancomycin

2012
[Treatment of refractory or recurrent Clostridium difficile infection].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2012, Volume: 60, Issue:2

    Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Probiotics; Recurrence; Vancomycin

2012
Changing epidemiology of Clostridium difficile-associated disease during stem cell transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2013, Volume: 19, Issue:3

    Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Aztreonam; Chicago; Ciprofloxacin; Clostridioides difficile; Enterococcus faecium; Enterocolitis, Pseudomembranous; Female; Graft vs Host Disease; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Risk Factors; Survival Rate; Transplantation, Homologous; Vancomycin; Vancomycin Resistance

2013
Epidemiology, diagnosis and treatment of Clostridium difficile infection.
    Expert review of anti-infective therapy, 2012, Volume: 10, Issue:12

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Risk Factors; Secondary Prevention; Severity of Illness Index; Treatment Outcome; Vancomycin

2012
Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-15, Volume: 35, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Colitis; Drug Administration Routes; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Radiography; Risk Factors; Treatment Outcome; Vancomycin

2002
[Pseudo-membranous colitis].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2

    Topics: Bacterial Proteins; Bacterial Toxins; Biomarkers; Clostridioides difficile; Cross Infection; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Humans; Vancomycin

2003
[Treatment of infections associated with Clostridium difficile].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2003, Volume: 56, Issue:5-6

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Risk Factors; Species Specificity; Vancomycin

2003
[4 cases of pseudomembranous colitis due to antituberculous agents].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2004, Volume: 101, Issue:8

    Topics: Aged; Aged, 80 and over; Antitubercular Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Lactobacillus acidophilus; Male; Treatment Outcome; Vancomycin

2004
Clostridium difficile--associated diarrhea.
    American family physician, 2005, Mar-01, Volume: 71, Issue:5

    Topics: Aged; Algorithms; Anti-Infective Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Humans; Metronidazole; Vancomycin

2005
Antibiotic-associated diarrhea and pseudomembranous colitis: are they less common with poorly absorbed antimicrobials?
    Chemotherapy, 2005, Volume: 51 Suppl 1

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Clinical Trials as Topic; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Intestinal Absorption; Lactobacillus; Metronidazole; Probiotics; Vancomycin

2005
Clinical manifestations, treatment and control of infections caused by Clostridium difficile.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11 Suppl 4

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Infection Control; Metronidazole; Vancomycin

2005
Treatment of Clostridium difficile-associated disease: old therapies and new strategies.
    The Lancet. Infectious diseases, 2005, Volume: 5, Issue:9

    Topics: Anti-Infective Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Probiotics; Secondary Prevention; Vaccination; Vancomycin; Vancomycin Resistance

2005
Clostridium difficile associated diarrhoea: diagnosis and treatment.
    BMJ (Clinical research ed.), 2005, Sep-03, Volume: 331, Issue:7515

    Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance; Enterocolitis, Pseudomembranous; Feces; Humans; Metronidazole; Risk Factors; Secondary Prevention; Vancomycin

2005
Past, present, and future therapies for Clostridium difficile-associated disease.
    The Annals of pharmacotherapy, 2006, Volume: 40, Issue:12

    Topics: Clostridioides difficile; Enterocolitis, Pseudomembranous; Forecasting; Humans; Metronidazole; Probiotics; Recurrence; Vancomycin

2006
Clostridium difficile-associated disease.
    South Dakota medicine : the journal of the South Dakota State Medical Association, 2006, Volume: 59, Issue:12

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Humans; Metronidazole; Probiotics; Proton Pump Inhibitors; Recurrence; Risk Factors; Saccharomyces; Vancomycin

2006
Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
    The Cochrane database of systematic reviews, 2007, Jul-18, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Metronidazole; Teicoplanin; Treatment Outcome; Vancomycin

2007
Clostridium difficile.
    Clinical journal of oncology nursing, 2007, Volume: 11, Issue:6

    Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Beclomethasone; Biopsy; Budesonide; Clostridioides difficile; Colonoscopy; Enterocolitis, Pseudomembranous; Feces; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infection Control; Male; Metronidazole; Middle Aged; Oncology Nursing; Primary Myelofibrosis; Risk Factors; Tacrolimus; Vancomycin

2007
Treatment of Clostridium difficile infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Jan-15, Volume: 46 Suppl 1

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Disease Management; Enterocolitis, Pseudomembranous; Humans; Metronidazole; North America; Recurrence; Therapies, Investigational; Vancomycin

2008
Current and future treatment modalities for Clostridium difficile-associated disease.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Apr-15, Volume: 65, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Vaccines; Clostridioides difficile; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin

2008
The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, May-15, Volume: 46, Issue:10

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; History, 20th Century; History, 21st Century; Humans; Metronidazole; Vancomycin

2008
Clostridium difficile colitis.
    Advances in internal medicine, 1984, Volume: 29

    Topics: Adult; Animals; Anti-Bacterial Agents; Carrier State; Child; Clostridium; Clostridium Infections; Colitis; Colitis, Ulcerative; Cricetinae; Crohn Disease; Cross Infection; Cytotoxins; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Humans; Infant; Infant, Newborn; Vancomycin

1984
Pseudomembranous colitis: a case report and literature review.
    The West Virginia medical journal, 1984, Volume: 80, Issue:6

    Topics: Aged; Bacitracin; Enterocolitis, Pseudomembranous; Erythromycin; Female; Humans; Metronidazole; Vancomycin

1984
Antibiotic-associated colitis.
    Disease-a-month : DM, 1984, Volume: 30, Issue:15

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cholestyramine Resin; Clindamycin; Clostridium; Clostridium Infections; Colitis; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Fluid Therapy; Humans; Metronidazole; Recurrence; Staphylococcal Infections; Vancomycin

1984
Treatment of pseudomembranous colitis and antibiotic-associated diarrhoea.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 14 Suppl D

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacitracin; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Middle Aged; Recurrence; Vancomycin

1984
[Antibiotic-associated diarrhoea and enterocolitis (author's transl)].
    Klinische Wochenschrift, 1980, Apr-01, Volume: 58, Issue:7

    Topics: Adult; Anti-Bacterial Agents; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Vancomycin

1980
Pseudomembranous (antibiotic-associated) colitis.
    Journal of the American Academy of Dermatology, 1981, Volume: 4, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Cholestyramine Resin; Clostridium; Colestipol; Colon; Enterocolitis, Pseudomembranous; Humans; Prognosis; Vancomycin

1981
[Pseudomembranous colitis. Aetiology, clinic and treatment (author's transl)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1982, Jan-19, Volume: 71, Issue:3

    Topics: Cholestyramine Resin; Clindamycin; Clostridium Infections; Enterocolitis, Pseudomembranous; Gastrointestinal Diseases; Humans; Ischemia; Lincomycin; Metals; Staphylococcal Infections; Tetracycline; Vancomycin

1982
Pseudomembranous colitis.
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1982, Jan-19, Volume: 71, Issue:3

    Topics: Anion Exchange Resins; Anti-Bacterial Agents; Clindamycin; Clostridium Infections; Cytotoxins; Enterocolitis, Pseudomembranous; Feces; Humans; Intestinal Mucosa; Leukocytes; Lincomycin; Metronidazole; Vancomycin

1982
Pseudomembranous colitis: pathogenesis and therapy.
    The Medical clinics of North America, 1982, Volume: 66, Issue:3

    Topics: Anti-Bacterial Agents; Atropine; Bacitracin; Botulinum Toxins; Cholestyramine Resin; Clostridium; Clostridium Infections; Colestipol; Diphenoxylate; Drug Combinations; Enterocolitis, Pseudomembranous; Gastrointestinal Agents; Humans; Intestinal Mucosa; Metronidazole; Vancomycin

1982
Diarrhea associated with parenteral vancomycin therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 20, Issue:6

    Topics: Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Kidney Failure, Chronic; Male; Middle Aged; Staphylococcal Infections; Vancomycin

1995
Rectal use of vancomycin.
    The Annals of pharmacotherapy, 1994, Volume: 28, Issue:12

    Topics: Administration, Oral; Administration, Rectal; Clostridioides difficile; Enema; Enterocolitis, Pseudomembranous; Humans; Injections, Intravenous; Metronidazole; Vancomycin

1994
Update on Clostridium difficile-induced colitis, Part 2.
    American journal of hospital pharmacy, 1994, Aug-01, Volume: 51, Issue:15

    Topics: Administration, Oral; Anti-Bacterial Agents; Capsules; Clostridioides difficile; Drug Costs; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin

1994
Clostridium difficile infection: a common clinical problem for the general internist.
    Journal of general internal medicine, 1994, Volume: 9, Issue:9

    Topics: Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Family Practice; Humans; Metronidazole; Vancomycin

1994
Antibiotic-induced diarrhea and pseudomembranous colitis.
    Postgraduate medicine, 1994, Volume: 95, Issue:8

    Topics: Administration, Oral; Anti-Bacterial Agents; Cluster Analysis; Cross Infection; Cytotoxins; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Incidence; Infection Control; Metronidazole; Primary Prevention; Sensitivity and Specificity; Sigmoidoscopy; Vancomycin

1994
Surgery for pancreatic tumors during pregnancy: a case report and review of the literature.
    American journal of perinatology, 1996, Volume: 13, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Cerebral Hemorrhage; Cesarean Section; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fetal Distress; Fluid Therapy; Humans; Infant, Newborn; Pancreatic Neoplasms; Postoperative Complications; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Risk Factors; Vancomycin

1996
Clostridium difficile colitis in the critically ill.
    Diseases of the colon and rectum, 1996, Volume: 39, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Colectomy; Combined Modality Therapy; Critical Illness; Enterocolitis, Pseudomembranous; Female; Hospital Mortality; Humans; Male; Metronidazole; Middle Aged; Morbidity; Retrospective Studies; Treatment Outcome; Vancomycin

1996
Nosocomial infections and nosocomial pneumonia.
    American journal of surgery, 1996, Volume: 172, Issue:6A

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Humans; Pneumonia, Bacterial; Surgical Wound Infection; Urinary Tract Infections; Vancomycin

1996
Clostridium difficile infection.
    Annual review of medicine, 1998, Volume: 49

    Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Colon; Diarrhea; Drug Costs; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Exotoxins; Feces; Hospitalization; Humans; Intestinal Mucosa; Metronidazole; Recurrence; Time Factors; Vancomycin

1998
Clostridium difficile infection in patients with reactive arthritis of undetermined etiology.
    Scandinavian journal of rheumatology, 1998, Volume: 27, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Arthritis, Reactive; Bacterial Toxins; Clostridioides difficile; Diagnosis, Differential; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Enterotoxins; Enzyme-Linked Immunosorbent Assay; Feces; Female; Humans; Male; Prognosis; Prohibitins; Treatment Outcome; Vancomycin

1998
[Pseudomembranous colitis (Clostridium difficile infection)].
    Ryoikibetsu shokogun shirizu, 1999, Issue:23 Pt 1

    Topics: Anti-Bacterial Agents; Antitrichomonal Agents; Clostridioides difficile; Diagnosis, Differential; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Prognosis; Vancomycin

1999
Update on Clostridium difficile infection.
    Current gastroenterology reports, 2000, Volume: 2, Issue:4

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin

2000
Treatment of Clostridium difficile-associated diarrhea and colitis.
    Current topics in microbiology and immunology, 2000, Volume: 250

    Topics: Abdomen, Acute; Anti-Bacterial Agents; Antidiarrheals; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Colectomy; Colitis; Combined Modality Therapy; Contraindications; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Fluid Therapy; Humans; Intestinal Perforation; Megacolon, Toxic; Metronidazole; Prospective Studies; Randomized Controlled Trials as Topic; Vancomycin

2000
Clostridial enterocolitis.
    The Veterinary clinics of North America. Equine practice, 2000, Volume: 16, Issue:3

    Topics: Animals; Bacitracin; Clostridioides difficile; Clostridium Infections; Clostridium perfringens; Disease Outbreaks; Enterocolitis, Pseudomembranous; Horse Diseases; Horses; Metronidazole; Vancomycin

2000
Clostridium difficile--Associated diarrhea: A review.
    Archives of internal medicine, 2001, Feb-26, Volume: 161, Issue:4

    Topics: Clostridioides difficile; Colon; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Practice Guidelines as Topic; Radiography; Vancomycin

2001
Recurrent Clostridium difficile diarrhoea.
    Gut, 2001, Volume: 49, Issue:1

    Topics: Anion Exchange Resins; Anti-Bacterial Agents; Anti-Infective Agents; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Metronidazole; Probiotics; Recurrence; Vancomycin

2001
[Diarrhea due to Clostridium difficile toxin in hemato-oncological patients].
    Nederlands tijdschrift voor geneeskunde, 2001, Jun-16, Volume: 145, Issue:24

    Topics: Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Clostridioides difficile; Dexamethasone; Diarrhea; Doxorubicin; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Middle Aged; Multiple Myeloma; Treatment Outcome; Vancomycin; Vincristine

2001
New indications for old antibiotics: tetracycline, erythromycin, carbenicillin, and vancomycin revisited.
    Southern medical journal, 1979, Volume: 72, Issue:6

    Topics: Anti-Bacterial Agents; Carbenicillin; Clindamycin; Diarrhea; Enterocolitis, Pseudomembranous; Erythromycin; Humans; Legionnaires' Disease; Lung Diseases; Male; Methicillin; Penicillin Resistance; Prostatitis; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Tetracycline; Urethritis; Vancomycin

1979
[Antibiotics and pseudomembranous colitis].
    Recenti progressi in medicina, 1979, Volume: 67, Issue:3

    Topics: Anti-Bacterial Agents; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Parenteral Nutrition, Total; Vancomycin; Water-Electrolyte Balance

1979
Vancomycin revisited.
    Annals of internal medicine, 1978, Volume: 88, Issue:6

    Topics: Bacteria; Bacterial Infections; Central Nervous System Diseases; Diphtheria; Drug Hypersensitivity; Endocarditis, Bacterial; Enterocolitis, Pseudomembranous; Humans; Penicillins; Renal Dialysis; Staphylococcal Infections; Vancomycin

1978
Antibiotic-associated colitis.
    Clinics in gastroenterology, 1979, Volume: 8, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Culture Techniques; Disease Models, Animal; Enterocolitis, Pseudomembranous; Feces; Humans; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1979
Clostridium difficile infection: responses, relapses and re-infections.
    The Journal of hospital infection, 1992, Volume: 22, Issue:2

    Topics: Clinical Trials as Topic; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Infection Control; Metronidazole; Recurrence; Vancomycin

1992
[Current status of Clostridium difficile: recent advances in diagnostic materials and treatment of colitis and diarrheas associated with antibiotic therapy].
    Annales de gastroenterologie et d'hepatologie, 1991, Volume: 27, Issue:7

    Topics: Causality; Clinical Protocols; Colectomy; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Recurrence; Vancomycin

1991
Oral vancomycin-induced rash: case report and review of the literature.
    DICP : the annals of pharmacotherapy, 1991, Volume: 25, Issue:12

    Topics: Administration, Oral; Aged; Aged, 80 and over; Drug Eruptions; Enterocolitis, Pseudomembranous; Female; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Pruritus; Vancomycin

1991
[Pseudomembranous colitis: a clinical analysis and review of literatures].
    Changgeng yi xue za zhi, 1991, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Vancomycin

1991
Update on pseudomembranous colitis.
    The Western journal of medicine, 1989, Volume: 151, Issue:6

    Topics: Enterocolitis, Pseudomembranous; Humans; Metronidazole; Patient Isolation; United States; Vancomycin

1989
[Pseudomembraneous colitis following antibiotic administration--a diagnostic and therapeutic challenge].
    Medizinische Klinik (Munich, Germany : 1983), 1988, Mar-18, Volume: 83, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Female; Humans; Intestinal Mucosa; Middle Aged; Ofloxacin; Oxazines; Vancomycin

1988
Fulminant colitis complicating antibiotic-associated pseudomembranous colitis: case report and review of the clinical manifestations and treatment.
    The American journal of gastroenterology, 1987, Volume: 82, Issue:4

    Topics: Clindamycin; Colectomy; Colitis, Ulcerative; Enterocolitis, Pseudomembranous; Humans; Ileostomy; Male; Middle Aged; Proctoscopy; Vancomycin

1987
Vancomycin and novobiocin.
    The Medical clinics of North America, 1970, Volume: 54, Issue:5

    Topics: Deafness; Drug Eruptions; Drug Hypersensitivity; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterocolitis, Pseudomembranous; Fever; Humans; Novobiocin; Sepsis; Staphylococcal Infections; Vancomycin

1970

Trials

37 trial(s) available for vancomycin and Antibiotic-Associated Colitis

ArticleYear
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.
    The Lancet. Infectious diseases, 2018, Volume: 18, Issue:3

    Topics: Aged; Aged, 80 and over; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Male; Middle Aged; Vancomycin

2018
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions.
    Alimentary pharmacology & therapeutics, 2018, Volume: 48, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colonoscopy; Combined Modality Therapy; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Feces; Female; Humans; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Vancomycin

2018
Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jul-01, Volume: 31, Issue:19

    Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Double-Blind Method; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Secondary Prevention; Treatment Outcome; Vancomycin

2013
[Challenges of Clostridium difficile infection].
    Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2013, Volume: 108, Issue:8

    Topics: Aminoglycosides; Biodiversity; Cause of Death; Colonoscopy; Cross Infection; Disinfection; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Hospital Mortality; Humans; Metronidazole; Patient Readmission; Prognosis; Recurrence; Tomography, X-Ray Computed; Transplantation; Vancomycin

2013
Outcomes of Clostridium difficile infection in recipients of solid abdominal organ transplants.
    Clinical transplantation, 2014, Volume: 28, Issue:2

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Hospitalization; Humans; Kidney Transplantation; Length of Stay; Liver Transplantation; Male; Middle Aged; Prognosis; Retrospective Studies; Vancomycin; Wisconsin

2014
[Recurrent Clostridium difficile infection. Treatment with duodenal infusion of donor feces].
    Der Internist, 2014, Volume: 55, Issue:4

    Topics: Adult; Combined Modality Therapy; Drug Resistance, Microbial; Early Termination of Clinical Trials; Enema; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Isotonic Solutions; Male; Metronidazole; Retreatment; Secondary Prevention; Vancomycin

2014
Fecal microbiota transplant after hematopoietic SCT: report of a successful case.
    Bone marrow transplantation, 2015, Volume: 50, Issue:1

    Topics: Allografts; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Hematopoietic Stem Cell Transplantation; Humans; Metronidazole; Microbiota; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vancomycin

2015
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection.
    Alimentary pharmacology & therapeutics, 2015, Volume: 41, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Clostridioides difficile; Clostridium Infections; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Microbiota; Middle Aged; Treatment Outcome; Vancomycin

2015
Assessment of Clostridium difficile Burden in Patients Over Time With First Episode Infection Following Fidaxomicin or Vancomycin.
    Infection control and hospital epidemiology, 2016, Volume: 37, Issue:2

    Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Colony Count, Microbial; Connecticut; Enterocolitis, Pseudomembranous; Feces; Female; Fidaxomicin; Humans; Male; Middle Aged; Polymerase Chain Reaction; Vancomycin

2016
Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Feb-01, Volume: 64, Issue:3

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Female; Humans; Male; Microbiota; Middle Aged; Ontario; Recurrence; Vancomycin; Young Adult

2017
Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Feb-15, Volume: 48, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Double-Blind Method; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Nitro Compounds; Prospective Studies; Thiazoles; Treatment Outcome; United States; Vancomycin

2009
Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection.
    Infection control and hospital epidemiology, 2010, Volume: 31, Issue:1

    Topics: Aged; Aged, 80 and over; Bacterial Typing Techniques; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Environmental Microbiology; Feces; Female; Hospital Units; Humans; Male; Metronidazole; Middle Aged; Ribotyping; Skin; Spores, Bacterial; Treatment Outcome; Vancomycin

2010
Treatment with monoclonal antibodies against Clostridium difficile toxins.
    The New England journal of medicine, 2010, Jan-21, Volume: 362, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antibodies; Antibodies, Monoclonal; Antitoxins; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Humans; Male; Metronidazole; Middle Aged; Secondary Prevention; Vancomycin; Young Adult

2010
Systemic absorption of oral vancomycin in patients with Clostridium difficile infection.
    Scandinavian journal of infectious diseases, 2011, Volume: 43, Issue:5

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Immunoassay; Intestinal Absorption; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Vancomycin

2011
Fidaxomicin versus vancomycin for Clostridium difficile infection.
    The New England journal of medicine, 2011, Feb-03, Volume: 364, Issue:5

    Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Enterocolitis, Pseudomembranous; Feces; Female; Fidaxomicin; Humans; Intention to Treat Analysis; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Secondary Prevention; Treatment Outcome; Vancomycin

2011
Comparative susceptibilities to fidaxomicin (OPT-80) of isolates collected at baseline, recurrence, and failure from patients in two phase III trials of fidaxomicin against Clostridium difficile infection.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:11

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Male; Prohibitins; Vancomycin

2011
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial.
    The Lancet. Infectious diseases, 2012, Volume: 12, Issue:4

    Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Double-Blind Method; Enterocolitis, Pseudomembranous; Feces; Female; Fidaxomicin; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prospective Studies; Vancomycin

2012
Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostridium difficile strain M3, in healthy subjects.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:10

    Topics: Adolescent; Adult; Clostridioides difficile; Double-Blind Method; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Spores, Bacterial; Vancomycin; Young Adult

2012
Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a LID on antibiotic use.
    Infection control and hospital epidemiology, 2012, Volume: 33, Issue:12

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Clindamycin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Infectious Disease Medicine; Long-Term Care; Nitrofurantoin; Nursing Homes; Referral and Consultation; Regression Analysis; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

2012
Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.
    The American journal of gastroenterology, 2002, Volume: 97, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Recurrence; Remission Induction; Risk Factors; Vancomycin

2002
Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2005, Volume: 3, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antidiarrheals; Bifidobacterium; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Oligosaccharides; Probiotics; Secondary Prevention; Treatment Outcome; Vancomycin

2005
Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Aug-15, Volume: 43, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Diarrhea; Double-Blind Method; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Humans; Ions; Male; Middle Aged; Polymers; Polystyrenes; Sulfonic Acids; Vancomycin

2006
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Aug-01, Volume: 45, Issue:3

    Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Clostridioides difficile; Double-Blind Method; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome; Vancomycin

2007
Therapeutic trials of antibiotic associated colitis.
    Scandinavian journal of infectious diseases. Supplementum, 1980, Issue:Suppl 22

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clinical Trials as Topic; Clostridium; Clostridium Infections; Colestipol; Double-Blind Method; Enterocolitis, Pseudomembranous; Feces; Humans; Polyamines; Vancomycin

1980
Clostridium difficile-associated diarrhea in patients with HIV positivity and AIDS: a prospective controlled study.
    The American journal of gastroenterology, 1994, Volume: 89, Issue:8

    Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; HIV Seropositivity; Humans; Male; Metronidazole; Prospective Studies; Vancomycin

1994
Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 22, Issue:5

    Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fusidic Acid; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Teicoplanin; Vancomycin

1996
Recurrent Clostridium difficile disease: epidemiology and clinical characteristics.
    Infection control and hospital epidemiology, 1999, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Health Care Costs; Hospitalization; Humans; Incidence; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Vancomycin

1999
The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Combined Modality Therapy; Double-Blind Method; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Middle Aged; Probiotics; Recurrence; Saccharomyces; Vancomycin

2000
Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.
    British medical journal, 1978, Dec-16, Volume: 2, Issue:6153

    Topics: Bacterial Toxins; Clinical Trials as Topic; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Postoperative Complications; Random Allocation; Vancomycin

1978
Pseudomembranous colitis.
    Journal of clinical gastroenterology, 1979, Volume: 1, Issue:3

    Topics: Anti-Bacterial Agents; Cholestyramine Resin; Clinical Trials as Topic; Enterocolitis, Pseudomembranous; Humans; Vancomycin

1979
Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial.
    Annals of internal medicine, 1992, Aug-15, Volume: 117, Issue:4

    Topics: Aged; Bacterial Typing Techniques; Carrier State; Clostridioides difficile; Clostridium Infections; Cross Infection; DNA Restriction Enzymes; Enterocolitis, Pseudomembranous; Feces; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Prohibitins; Vancomycin

1992
Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:10

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Middle Aged; Prospective Studies; Teicoplanin; Vancomycin

1992
Enterobacteriaceae and neonatal necrotising enterocolitis.
    Archives of disease in childhood, 1992, Volume: 67, Issue:1 Spec No

    Topics: Aztreonam; Drug Therapy, Combination; England; Enterobacteriaceae Infections; Enterocolitis, Pseudomembranous; Gentamicins; Humans; Incidence; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Intestine, Large; Vancomycin

1992
The role of anion-exchange resins in the treatment of antibiotic-associated pseudomembranous colitis.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1990, May-15, Volume: 142, Issue:10

    Topics: Adult; Anion Exchange Resins; Child; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Ion Exchange Resins; Metronidazole; Vancomycin

1990
Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.
    The American journal of gastroenterology, 1989, Volume: 84, Issue:10

    Topics: Antidiarrheals; Clinical Trials as Topic; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Recurrence; Vancomycin; Yeast, Dried

1989
Treatment of Clostridium difficile colitis.
    Gastroenterology, 1985, Volume: 89, Issue:5

    Topics: Animals; Bacitracin; Clinical Trials as Topic; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Metronidazole; Random Allocation; Vancomycin

1985
Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin.
    Gastroenterology, 1985, Volume: 89, Issue:5

    Topics: Adult; Aged; Bacitracin; Bacterial Toxins; Clostridium; Double-Blind Method; Drug Evaluation; Enterocolitis, Pseudomembranous; Feces; Humans; Middle Aged; Random Allocation; Vancomycin

1985

Other Studies

397 other study(ies) available for vancomycin and Antibiotic-Associated Colitis

ArticleYear
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Microbial Sensitivity Tests; United States

2007
Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Animals; Anti-Infective Agents; Clostridioides difficile; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Mesocricetus; Rifamycins; Rifaximin; Treatment Outcome; Vancomycin; Weight Gain

2008
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Prognosis; Quebec; Ribotyping; Risk Factors

2008
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests

2008
Effects of inoculum, pH, and cations on the in vitro activity of fidaxomicin (OPT-80, PAR-101) against Clostridium difficile.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Agar; Aminoglycosides; Anti-Bacterial Agents; Cations; Clostridioides difficile; Colony Count, Microbial; Culture Media; Enterocolitis, Pseudomembranous; Fidaxomicin; Glycosides; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Microbial Sensitivity Tests

2010
Discovery of LFF571: an investigational agent for Clostridium difficile infection.
    Journal of medicinal chemistry, 2012, Mar-08, Volume: 55, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Crystallography, X-Ray; Enterococcus; Enterocolitis, Pseudomembranous; Escherichia coli Proteins; Female; Male; Mesocricetus; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Peptide Elongation Factor Tu; Rats; Rats, Sprague-Dawley; Solubility; Staphylococcus aureus; Streptococcus pyogenes; Structure-Activity Relationship; Thiazoles; Water

2012
Structure-Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea.
    Journal of medicinal chemistry, 2015, Jun-25, Volume: 58, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Lipopeptides; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Structure-Activity Relationship

2015
Seeing C diff differently.
    The lancet. Gastroenterology & hepatology, 2022, Volume: 7, Issue:3

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Consumer Health Information; Cost of Illness; Enterocolitis, Pseudomembranous; False Negative Reactions; Humans; Metronidazole; Vancomycin

2022
Commentary: faecal microbiota transplantation-from home brew to holy grail.
    Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:1

    Topics: Clostridium Infections; Colonoscopy; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Humans; Vancomycin

2020
Successful Treatment of Pseudomembranous Colitis with Fecal Microbiota Transplantation - A Case Study on A Patient Rescued by Extracorporeal Cardiopulmonary Resuscitation After Cardiac Arrest.
    Annals of transplantation, 2020, Jul-01, Volume: 25

    Topics: Adolescent; Anti-Bacterial Agents; Cardiopulmonary Resuscitation; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Female; Heart Arrest; Humans; Metronidazole; Treatment Outcome; Vancomycin

2020
Repurposing the Veterinary Antiprotozoal Drug Ronidazole for the Treatment of Clostridioides difficile Infection.
    International journal of antimicrobial agents, 2020, Volume: 56, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Caco-2 Cells; Cell Line, Tumor; Clostridioides difficile; Disease Models, Animal; Drug Repositioning; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Mice; Microbial Sensitivity Tests; Ronidazole; Vancomycin; Veterinary Drugs

2020
Cec and You Shall Find: Cecal Perforation in a Patient with COVID-19.
    Digestive diseases and sciences, 2021, Volume: 66, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Cecal Diseases; Cecum; Clostridioides difficile; COVID-19; Enterocolitis, Pseudomembranous; Humans; Intestinal Perforation; Male; SARS-CoV-2; Vancomycin

2021
Effect of oral vancomycin dose on outcomes in patients with Clostridioides difficile infection.
    International journal of antimicrobial agents, 2021, Volume: 57, Issue:4

    Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Standard of Care; Treatment Outcome; Vancomycin

2021
The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Minocycline; Polymerase Chain Reaction; Retrognathia; Tigecycline; Vancomycin

2018
An extremely high bioavailability of orally administered vancomycin in a patient with severe colitis and renal insufficiency.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:12

    Topics: Acute Kidney Injury; Administration, Oral; Anti-Bacterial Agents; Antineoplastic Agents; Biological Availability; Colonoscopy; Enterocolitis, Pseudomembranous; Humans; Intestine, Large; Male; Middle Aged; Rectal Neoplasms; Renal Replacement Therapy; Respiration, Artificial; Sepsis; Vancomycin

2017
Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
    Gastroenterology, 2018, Volume: 154, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Gastrointestinal Microbiome; Intestines; Mice; Mice, Inbred C57BL; Steroids; Vancomycin

2018
Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
    International journal of medical microbiology : IJMM, 2018, Volume: 308, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Fluoroquinolones; Humans; Lebanon; Male; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Phenotype; Ribotyping; Vancomycin

2018
Repeated Clostridium difficile infection after living donor liver transplantation.
    Clinical journal of gastroenterology, 2018, Volume: 11, Issue:4

    Topics: Anti-Bacterial Agents; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Immunosuppressive Agents; Length of Stay; Liver Transplantation; Living Donors; Middle Aged; Postoperative Complications; Recurrence; Risk Factors; Vancomycin

2018
Clostridium difficile cure with fecal microbiota transplantation in a child with Pompe disease: a case report.
    Journal of medical case reports, 2018, Apr-28, Volume: 12, Issue:1

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Female; Glycogen Storage Disease Type II; Humans; Immunocompetence; Infant; Metronidazole; Polymerase Chain Reaction; Treatment Outcome; Vancomycin

2018
Comparison of the in vitro antibacterial activity of Ramizol, fidaxomicin, vancomycin, and metronidazole against 100 clinical isolates of Clostridium difficile by broth microdilution.
    Diagnostic microbiology and infectious disease, 2018, Volume: 92, Issue:3

    Topics: Anti-Bacterial Agents; Benzoates; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Inhibitory Concentration 50; Metronidazole; Microbial Sensitivity Tests; Stilbenes; Vancomycin

2018
Cost-effectiveness analysis of ribotype-guided fecal microbiota transplantation in Chinese patients with severe Clostridium difficile infection.
    PloS one, 2018, Volume: 13, Issue:7

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Asian People; China; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Decision Support Techniques; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Female; Gene Frequency; Humans; Male; Middle Aged; Ribotyping; Severity of Illness Index; Survival Rate; Treatment Outcome; Vancomycin

2018
A Case of Recurring Diarrhea in a Young Woman.
    Gastroenterology, 2019, Volume: 156, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Klebsiella Infections; Klebsiella oxytoca; Recurrence; Vancomycin

2019
A multicenter-based study on epidemiology, antibiotic susceptibility and risk factors of toxigenic Clostridium difficile in hospitalized patients in southwestern Iran.
    Le infezioni in medicina, 2018, Dec-01, Volume: 26, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Clostridioides difficile; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Hospitals, Teaching; Humans; Iran; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Vancomycin; Young Adult

2018
Clostridium difficile-associated diarrhea following the therapy with antibiotic and proton pump inhibitors in a 77-year-old man with several comorbidities: A case report.
    Medicine, 2019, Volume: 98, Issue:13

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Comorbidity; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Proton Pump Inhibitors; Vancomycin

2019
Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Europe; Fidaxomicin; Humans; Metronidazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Thiazoles; Treatment Outcome; Vancomycin

2013
Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
    The Journal of thoracic and cardiovascular surgery, 2013, Volume: 146, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Clostridioides difficile; Coronary Artery Bypass; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Propensity Score; Proportional Hazards Models; Risk Assessment; Risk Factors; Surgical Wound Infection; Time Factors; Treatment Outcome; United States; Vancomycin

2013
Intracolonic vancomycin for severe Clostridium difficile colitis.
    Surgical infections, 2013, Volume: 14, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Enema; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Vancomycin

2013
Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6

    Topics: Anti-Bacterial Agents; Bacteriocins; Clostridioides difficile; Depsipeptides; Drug Synergism; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Peptides; Vancomycin

2013
Concomitant typhlitis and Clostridium difficile colitis developed after first R-CHOP chemotherapy in a non-Hodgkin lymphoma patient.
    BMJ case reports, 2013, Apr-17, Volume: 2013

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Clostridioides difficile; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Prednisone; Radiography; Rituximab; Typhlitis; Vancomycin; Vincristine

2013
[Clostridium difficile infections - still a major challenge].
    MMW Fortschritte der Medizin, 2013, Apr-18, Volume: 155, Issue:7

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Combined Modality Therapy; Cross Infection; Disease Notification; Enterocolitis, Pseudomembranous; Fidaxomicin; Metronidazole; Probiotics; Vancomycin; Virulence

2013
Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials.
    American journal of nephrology, 2013, Volume: 38, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Severity of Illness Index; Treatment Outcome; Vancomycin; Young Adult

2013
A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2014, Volume: 20, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Endpoint Determination; Enterocolitis, Pseudomembranous; Female; Hematologic Neoplasms; Humans; Incidence; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin

2014
Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9

    Topics: Adult; Aged; Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Clinical Trials as Topic; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Hematopoietic Stem Cell Transplantation; Humans; Male; Metronidazole; Middle Aged; Organ Transplantation; Survival Analysis; Treatment Outcome; Vancomycin; Vancomycin Resistance

2013
Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure.
    PloS one, 2013, Volume: 8, Issue:7

    Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Cefepime; Cefuroxime; Cephalosporins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Odds Ratio; Polymorphism, Genetic; Risk Factors; Toll-Like Receptor 4; Vancomycin

2013
Medical research. The promise of poop.
    Science (New York, N.Y.), 2013, Aug-30, Volume: 341, Issue:6149

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Gastrointestinal Diseases; Humans; Metagenome; Randomized Controlled Trials as Topic; Transplantation; Vancomycin

2013
Fecal transplantation therapy for Clostridium difficile-associated pouchitis.
    International journal of colorectal disease, 2014, Volume: 29, Issue:2

    Topics: Adult; Aminoglycosides; Child; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Humans; Male; Pouchitis; Rifamycins; Rifaximin; Vancomycin

2014
[Clostridium difficile infection (CDI) in the course of time - an issue only for the internist?].
    Zentralblatt fur Chirurgie, 2014, Volume: 139, Issue:4

    Topics: Aminoglycosides; Clostridioides difficile; Colectomy; Colostomy; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Germany; Humans; Incidence; Metronidazole; Recurrence; Transplantation; Vancomycin

2014
Colonic decompression and direct intraluminal medical therapy for Clostridium difficile-associated megacolon using a tube placed endoscopically in the proximal colon.
    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2014, Volume: 16, Issue:2

    Topics: Administration, Topical; Anti-Bacterial Agents; Clostridioides difficile; Colonoscopy; Decompression, Surgical; Enema; Enterocolitis, Pseudomembranous; Humans; Intubation, Gastrointestinal; Megacolon; Vancomycin

2014
Reply to M.R. Green et al.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Dec-01, Volume: 31, Issue:34

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Vancomycin

2013
Is fidaxomicin the drug of choice for treating Clostridium difficile-associated diarrhea in patients with cancer?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Dec-01, Volume: 31, Issue:34

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Vancomycin

2013
Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication.
    World journal of gastroenterology, 2013, Nov-14, Volume: 19, Issue:42

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clostridioides difficile; Colonoscopy; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Humans; Pantoprazole; Proton Pump Inhibitors; Risk Factors; Treatment Outcome; Vancomycin

2013
In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Fluoroquinolones; Humans; Linezolid; Male; Metronidazole; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Spores, Bacterial; Survival Analysis; Vancomycin

2014
[Clostridium difficile infection due to ribotype 027: description of an imported case in Spain].
    Enfermedades infecciosas y microbiologia clinica, 2014, Volume: 32, Issue:8

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clostridioides difficile; Disease Susceptibility; DNA, Bacterial; DNA, Ribosomal; Enterocolitis, Pseudomembranous; Female; Humans; Intubation, Intratracheal; Pneumonia, Bacterial; Portugal; Ribotyping; RNA, Bacterial; Sequence Deletion; Spain; Vancomycin; Young Adult

2014
Nonresectional surgical approach to toxic megacolon with abdominal compartment syndrome.
    The American surgeon, 2013, Volume: 79, Issue:12

    Topics: Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Ileostomy; Intra-Abdominal Hypertension; Male; Megacolon, Toxic; Middle Aged; Vancomycin

2013
Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center.
    Journal of gastrointestinal and liver diseases : JGLD, 2013, Volume: 22, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Community-Acquired Infections; Cross Infection; Enterocolitis, Pseudomembranous; Female; Hospitalization; Hospitals, Teaching; Humans; Kaplan-Meier Estimate; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Romania; Tertiary Care Centers; Time Factors; Treatment Outcome; Vancomycin; Young Adult

2013
Editorial Commentary: the trials and tribulations of treating Clostridium difficile infection-one step backward, one step forward, but still progress.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Aug-01, Volume: 59, Issue:3

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin

2014
Intestinal microbiota transplantation: a case of Crohn's colitis with superimposed Clostridium difficile infection.
    The West Indian medical journal, 2013, Volume: 62, Issue:7

    Topics: Addison Disease; Adult; Anti-Infective Agents; Clostridioides difficile; Crohn Disease; Enterocolitis, Pseudomembranous; Fatal Outcome; Feces; Female; Humans; Intestines; Metagenome; Metronidazole; Microbiota; Superinfection; Vancomycin

2013
A high-throughput small-molecule screen to identify a novel chemical inhibitor of Clostridium difficile.
    International journal of antimicrobial agents, 2014, Volume: 44, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; High-Throughput Screening Assays; Iron; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium bovis; Phenanthrolines; Small Molecule Libraries; Species Specificity; Vancomycin

2014
Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacterial Toxins; Clostridioides difficile; Edema; Enterocolitis, Pseudomembranous; Enterotoxins; Epithelial Cells; Fibroblasts; Fidaxomicin; Gene Expression; Ileum; Injections, Intralesional; Interleukin-1beta; Intestinal Mucosa; Male; Metronidazole; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; RNA, Messenger; Vancomycin

2014
Outcomes from rectal vancomycin therapy in patients with Clostridium difficile infection.
    The American journal of gastroenterology, 2014, Volume: 109, Issue:6

    Topics: Administration, Rectal; Aged; Anti-Bacterial Agents; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Treatment Outcome; Vancomycin

2014
Antibiotic overuse and Clostridium difficile: a teachable moment.
    JAMA internal medicine, 2014, Volume: 174, Issue:8

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fasciitis, Necrotizing; Fatal Outcome; Female; Humans; Imipenem; Inappropriate Prescribing; Streptococcal Infections; Streptococcus pyogenes; Vancomycin

2014
[Epidemiology of Clostridium difficile-associated disease (CDAD) in Salamanca].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2014, Volume: 27, Issue:2

    Topics: Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Clostridioides difficile; Clostridium Infections; Comorbidity; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, University; Humans; Incidence; Male; Metronidazole; Middle Aged; Neoplasms; Postoperative Complications; Recurrence; Spain; Surveys and Questionnaires; Vancomycin

2014
An agent-based simulation model for Clostridium difficile infection control.
    Medical decision making : an international journal of the Society for Medical Decision Making, 2015, Volume: 35, Issue:2

    Topics: Anti-Bacterial Agents; Biometry; Clostridioides difficile; Computer Simulation; Cross Infection; Enterocolitis, Pseudomembranous; Hospitals; Humans; Infection Control; Markov Chains; Risk Assessment; Vancomycin; Wisconsin

2015
[Systemic absorption of oral vancomycin in colitis patients. A propos of 2 cases].
    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2014, Jul-01, Volume: 38, Issue:4

    Topics: Absorption, Physiological; Administration, Oral; Aged, 80 and over; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Male; Vancomycin

2014
Appendicostomy for intraluminal antibiotic administration and extracorporeal membrane oxygenation support in severe Hirschsprung's enterocolitis.
    The American surgeon, 2014, Volume: 80, Issue:9

    Topics: Anal Canal; Anastomosis, Surgical; Anti-Bacterial Agents; Appendix; Clostridioides difficile; Colon, Sigmoid; Colostomy; Enterocolitis, Pseudomembranous; Extracorporeal Membrane Oxygenation; Feces; Hirschsprung Disease; Humans; Infant, Newborn; Male; Therapeutic Irrigation; Vancomycin

2014
Beneficial effect of oral tigecycline treatment on Clostridium difficile infection in gnotobiotic piglets.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clostridioides difficile; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Fluoroquinolones; Germ-Free Life; Humans; Interleukin-8; Microbiota; Minocycline; Pyrimidinones; Swine; Tigecycline; Vancomycin

2014
[Clostridium difficile in visceral surgery].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2015, Volume: 86, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Cross Infection; Cross-Sectional Studies; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Germany; Hospital Mortality; Humans; Incidence; Intensive Care Units; Male; Metronidazole; Middle Aged; Minocycline; Patient Readmission; Retrospective Studies; Survival Rate; Tigecycline; Vancomycin; Young Adult

2015
Emphysematous cystitis due to recurrent Clostridium difficile infection.
    BMJ case reports, 2014, Dec-17, Volume: 2014

    Topics: Aged; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cystitis; Emphysema; Enterocolitis, Pseudomembranous; Female; Humans; Intraabdominal Infections; Metronidazole; Recurrence; Urinary Bladder; Vancomycin

2014
Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Cecum; Clostridioides difficile; Colon; Enterocolitis, Pseudomembranous; Feces; Female; Male; Mice; Mice, Inbred C57BL; Minocycline; Tigecycline; Vancomycin

2015
A Wolf in Infection's Clothing: The Difficulties of Discerning Systemic Lupus Erythematosus from Its Infectious Sequelae.
    The American journal of medicine, 2015, Volume: 128, Issue:7

    Topics: Abdominal Pain; Biopsy, Needle; Clostridioides difficile; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Ganciclovir; Humans; Kidney Function Tests; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Middle Aged; Prednisolone; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vancomycin

2015
Antibiotics "just-in-case" in a patient with aspiration pneumonitis.
    JAMA internal medicine, 2015, Volume: 175, Issue:4

    Topics: Anti-Bacterial Agents; Cerebral Palsy; Clostridioides difficile; Enterocolitis, Pseudomembranous; Epilepsy, Tonic-Clonic; Fatal Outcome; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Aspiration; Radiography; Vancomycin

2015
Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection.
    Infection control and hospital epidemiology, 2015, Volume: 36, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Cost Savings; Cost-Benefit Analysis; Drug Costs; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Health Care Costs; Humans; Quality-Adjusted Life Years; Vancomycin

2015
The first Clostridium difficile ribotype 027 strain isolated in Taiwan.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2016, Volume: 115, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Clostridioides difficile; Enterocolitis, Pseudomembranous; Esophageal Neoplasms; Humans; Male; Metronidazole; Shock, Septic; Taiwan; Vancomycin

2016
Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Base Sequence; Berberine; Clostridioides difficile; Colitis; Disease Models, Animal; DNA, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Random Allocation; Recurrence; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin; Weight Loss

2015
Frozen encapsulated stool in recurrent Clostridium difficile: exploring the role of pills in the treatment hierarchy of fecal microbiota transplant nonresponders.
    The American journal of gastroenterology, 2015, Volume: 110, Issue:4

    Topics: Abdominal Pain; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Biological Therapy; Capsules; Clostridioides difficile; Colonoscopy; Diarrhea; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Feces; Female; Fidaxomicin; Freezing; Humans; Irritable Bowel Syndrome; Male; Metronidazole; Microbiota; Recurrence; Transplantation, Homologous; Treatment Outcome; Vancomycin

2015
Treatment of Clostridium difficile infection in a French university hospital.
    Scandinavian journal of gastroenterology, 2015, Volume: 50, Issue:10

    Topics: Adult; Aged; Clostridioides difficile; Cohort Studies; Cross Infection; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; France; Hospitals, University; Humans; Incidence; Male; Metronidazole; Middle Aged; Prospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vancomycin

2015
Identification of Recurrent Clostridium difficile Infection Using Administrative Codes: Accuracy and Implications for Surveillance.
    Infection control and hospital epidemiology, 2015, Volume: 36, Issue:8

    Topics: Administrative Claims, Healthcare; Aged; Algorithms; Anti-Bacterial Agents; Area Under Curve; Bacteriological Techniques; Clostridioides difficile; Drug Prescriptions; Enterocolitis, Pseudomembranous; Feces; Female; Humans; International Classification of Diseases; Male; Middle Aged; Population Surveillance; Predictive Value of Tests; Recurrence; ROC Curve; Vancomycin

2015
Characteristics and Antibiotic Use Associated With Short-Term Risk of Clostridium difficile Infection Among Hospitalized Patients.
    American journal of clinical pathology, 2015, Volume: 143, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Female; Humans; Inpatients; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Vancomycin

2015
Editorial Commentary: Critically Ill Patients With Clostridium difficile Infection: Are 2 Antibiotics Better Than One?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Sep-15, Volume: 61, Issue:6

    Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Vancomycin

2015
The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Sep-15, Volume: 61, Issue:6

    Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Anti-Infective Agents; Clostridioides difficile; Critical Illness; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Vancomycin

2015
Continuous Administration of Vancomycin through a Long Intestinal Tube for Clostridium difficile Infection.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:12

    Topics: Administration, Rectal; Aged; Anti-Bacterial Agents; Asian People; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Treatment Outcome; Vancomycin

2015
[Treatment of a severe Clostridium difficile infection with colonic lavages. Report of one case].
    Revista medica de Chile, 2015, Volume: 143, Issue:5

    Topics: Aged; Animals; Clostridioides difficile; Combined Modality Therapy; Enterocolitis, Pseudomembranous; Female; Humans; Ileostomy; Therapeutic Irrigation; Vancomycin

2015
Vancomycin-induced linear IgA bullous dermatosis demonstrating the isomorphic phenomenon.
    International journal of dermatology, 2015, Volume: 54, Issue:11

    Topics: Anti-Bacterial Agents; Brain Diseases; Clostridioides difficile; Drug Eruptions; Enterocolitis, Pseudomembranous; Fatal Outcome; Female; Humans; Linear IgA Bullous Dermatosis; Middle Aged; Mouth Diseases; Vancomycin

2015
U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Fluoroquinolones; Genes, Bacterial; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multiplex Polymerase Chain Reaction; Prohibitins; Sentinel Surveillance; United States; Vancomycin

2015
Diarrhea With Clostridium difficile-Positive Stool-Trick or Treat: A Teachable Moment.
    JAMA internal medicine, 2015, Volume: 175, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Axitinib; Carcinoma, Renal Cell; Clostridioides difficile; Costs and Cost Analysis; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Imidazoles; Indazoles; Metronidazole; Protein Kinase Inhibitors; Recurrence; Treatment Outcome; Vancomycin; Withholding Treatment

2015
Using a Novel Lysin To Help Control Clostridium difficile Infections.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Amidohydrolases; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Catalytic Domain; Clostridioides difficile; Colon; Drug Resistance, Multiple, Bacterial; Endopeptidases; Enterocolitis, Pseudomembranous; Female; Hydrogen-Ion Concentration; Mice, Inbred C57BL; Molecular Sequence Data; Prophages; Recombinant Proteins; Vancomycin; Viral Proteins

2015
Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Clostridioides difficile; Colony Count, Microbial; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Intestines; Metronidazole; Mice; Microbial Sensitivity Tests; Oxazolidinones; Streptococcal Infections; Treatment Outcome; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci

2016
[A Serious Case of Pseudomembranous Colitis in which Treatment with Endoscopic Vancomycin Sprinkling Got a Good Result].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2015, Volume: 89, Issue:3

    Topics: Aged; Colonoscopy; Enterocolitis, Pseudomembranous; Humans; Male; Treatment Outcome; Vancomycin

2015
Clinical and Healthcare Burden of Multiple Recurrences of Clostridium difficile Infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Mar-01, Volume: 62, Issue:5

    Topics: Anti-Bacterial Agents; Canada; Clostridioides difficile; Cohort Studies; Cost of Illness; Enterocolitis, Pseudomembranous; Hospitalization; Incidence; Metronidazole; Recurrence; Retrospective Studies; Risk Factors; Vancomycin

2016
The Uncertain Benefits of Combination Therapy for Clostridium difficile Infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Mar-15, Volume: 62, Issue:6

    Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Vancomycin

2016
Reply to Young, Ochi, and Marimuthu.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Mar-15, Volume: 62, Issue:6

    Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Vancomycin

2016
Hypo-Hypo: A Complex Metabolic Disorder.
    Annals of the American Thoracic Society, 2016, Volume: 13, Issue:1

    Topics: Acid-Base Equilibrium; Acidosis, Renal Tubular; Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fludrocortisone; Humans; Hyperkalemia; Hypoaldosteronism; Kidney; Male; Mineralocorticoids; Treatment Outcome; Vancomycin

2016
Efficacy of vancomycin extended-dosing regimens for treatment of simulated Clostridium difficile infection within an in vitro human gut model.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Load; Bacteroides fragilis; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Feces; Gastrointestinal Tract; Humans; Microbiota; Models, Biological; Recurrence; Vancomycin

2016
Clostridium difficile ileitis in a patient, after total colectomy.
    BMJ case reports, 2016, Feb-22, Volume: 2016

    Topics: Adenocarcinoma; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Colectomy; Colonic Neoplasms; Enterocolitis, Pseudomembranous; Humans; Ileitis; Male; Middle Aged; Polymerase Chain Reaction; Tomography, X-Ray Computed; Vancomycin

2016
Misanalysis of Urinalysis: A Teachable Moment.
    JAMA internal medicine, 2016, Volume: 176, Issue:4

    Topics: Analgesics, Opioid; Anti-Bacterial Agents; Cefpodoxime; Ceftizoxime; Clonidine; Diagnostic Errors; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Low Back Pain; Middle Aged; Muscle Relaxants, Central; Pyuria; Substance Withdrawal Syndrome; Tramadol; Urinalysis; Urinary Tract Infections; Vancomycin

2016
Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia.
    Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:12

    Topics: Anti-Bacterial Agents; Australia; Clostridioides difficile; Cost Savings; Cost-Benefit Analysis; Drug Costs; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Health Care Costs; Humans; Intestines; Markov Chains; Models, Economic; Quality of Life; Quality-Adjusted Life Years; Recurrence; Time Factors; Treatment Outcome; Vancomycin

2016
Clostridium difficile Associated Diarrhea.
    South Dakota medicine : the journal of the South Dakota State Medical Association, 2016, Volume: 69, Issue:3

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Humans; Metronidazole; Recurrence; Vancomycin

2016
Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
    Emerging microbes & infections, 2016, May-11, Volume: 5

    Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Communicable Diseases, Emerging; Costa Rica; Cross Infection; Diarrhea; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterocolitis, Pseudomembranous; Fluoroquinolones; Genes, Bacterial; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Ribotyping; Time Factors; Vancomycin

2016
Pseudomembranous colitis secondary to methicillin-resistant Staphylococcus aureus (MRSA).
    BMJ case reports, 2016, May-10, Volume: 2016

    Topics: Administration, Oral; Adult; Enterocolitis, Pseudomembranous; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Treatment Outcome; Vancomycin

2016
[Antibiotic treatment of clostridial colitis].
    Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 2016,Winter, Volume: 65, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Recurrence; Vancomycin

2016
The efficacy of intracolonic vancomycin for severe Clostridium difficile colitis: a case series.
    BMC infectious diseases, 2016, 07-07, Volume: 16

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colon; Drug Administration Routes; Enterocolitis, Pseudomembranous; Female; Humans; Intensive Care Units; Male; Megacolon, Toxic; Metronidazole; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin

2016
Pseudomembranous colitis presenting as a mechanical large bowel obstruction.
    ANZ journal of surgery, 2018, Volume: 88, Issue:9

    Topics: Administration, Intravenous; Administration, Oral; Anastomosis, Surgical; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Diatrizoate Meglumine; Enterocolitis, Pseudomembranous; Humans; Ileostomy; Intestinal Obstruction; Male; Metronidazole; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin

2018
Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016, Volume: 22, Issue:12

    Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Enterocolitis, Pseudomembranous; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Middle Aged; Minocycline; Recurrence; Retrospective Studies; Sepsis; Tigecycline; Treatment Outcome; Vancomycin

2016
[Clostridium difficile infection : What is currently available for treatment?]
    Der Internist, 2016, Volume: 57, Issue:12

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Evidence-Based Medicine; Fidaxomicin; Humans; Megacolon, Toxic; Metronidazole; Treatment Outcome; Vancomycin

2016
Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France.
    PloS one, 2017, Volume: 12, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Community-Acquired Infections; Computer Simulation; Cost-Benefit Analysis; Decision Trees; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; France; Health Care Costs; Humans; Models, Economic; Quality-Adjusted Life Years; Recurrence; Vancomycin

2017
Lack of Benefit With Combination Therapy for Clostridium difficile Infection.
    Infection control and hospital epidemiology, 2017, Volume: 38, Issue:5

    Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Clostridioides difficile; Combined Modality Therapy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Infant; Length of Stay; Male; Metronidazole; Middle Aged; Proportional Hazards Models; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vancomycin; Young Adult

2017
Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.
    Journal of clinical microbiology, 2017, Volume: 55, Issue:5

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Electronic Data Processing; Enterocolitis, Pseudomembranous; Evidence-Based Medicine; Female; Hospital Information Systems; Humans; Laxatives; Male; Metronidazole; Middle Aged; Vancomycin

2017
Effect of telephoned notification of positive Clostridium difficile test results on the time to the ordering of antimicrobial therapy.
    Infection control and hospital epidemiology, 2008, Volume: 29, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Disease Notification; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Humans; Length of Stay; Medical Records Systems, Computerized; Metronidazole; Practice Patterns, Physicians'; Telephone; Time Factors; Vancomycin

2008
Clostridium difficile enteritis following total colectomy.
    Techniques in coloproctology, 2008, Volume: 12, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Colitis, Ulcerative; Enterocolitis, Pseudomembranous; Humans; Male; Vancomycin

2008
Clostridium difficile pancolitis in adults with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2008, Volume: 7, Issue:5

    Topics: Adult; Clostridioides difficile; Cystic Fibrosis; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Steroids; Vancomycin

2008
In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:4

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Culture Media; DNA Fingerprinting; Enterocolitis, Pseudomembranous; Genotype; Glycopeptides; Humans; Lipoglycopeptides; Metronidazole; Microbial Sensitivity Tests; Ribotyping; Vancomycin

2008
Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridioides difficile; Colony Count, Microbial; DNA, Bacterial; Enterocolitis, Pseudomembranous; Glycopeptides; Humans; In Vitro Techniques; Lipoglycopeptides; Microbial Viability; Polymerase Chain Reaction; Ribotyping; Spores, Bacterial; Vancomycin

2008
Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
    Scandinavian journal of gastroenterology, 2009, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Clostridioides difficile; Colitis, Ulcerative; Colonoscopy; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin

2009
Metronidazole and vancomycin: equivalence of initial efficacy in CDAD.
    The American journal of gastroenterology, 2008, Volume: 103, Issue:8

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Treatment Outcome; Vancomycin

2008
[Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces].
    Nederlands tijdschrift voor geneeskunde, 2008, Aug-30, Volume: 152, Issue:35

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Middle Aged; Recurrence; Treatment Outcome; Vancomycin

2008
A mouse model of Clostridium difficile-associated disease.
    Gastroenterology, 2008, Volume: 135, Issue:6

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Disease Models, Animal; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Mice; Mice, Inbred C57BL; Severity of Illness Index; Vancomycin

2008
[Percutaneous endoscopic colostomy for treatment of an antibiotic-induced pseudomembranous colitis].
    Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:44

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Colonoscopy; Colostomy; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Metronidazole; Middle Aged; Pulmonary Disease, Chronic Obstructive; Vancomycin

2008
Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005.
    Emerging infectious diseases, 2008, Volume: 14, Issue:11

    Topics: Candida; Candidiasis; Clostridioides difficile; Drug Resistance, Fungal; Enterococcus; Enterocolitis, Pseudomembranous; Hospitalization; Hospitals; Humans; Incidence; Infection Control; Medical Records; Methicillin; Methicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin; Vancomycin Resistance

2008
Skin and environmental contamination with vancomycin-resistant Enterococci in patients receiving oral metronidazole or oral vancomycin treatment for Clostridium difficile-associated disease.
    Infection control and hospital epidemiology, 2009, Volume: 30, Issue:1

    Topics: Administration, Oral; Aged; Anti-Infective Agents; Clostridioides difficile; Enterococcus; Enterocolitis, Pseudomembranous; Environmental Microbiology; Equipment Contamination; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Skin; Vancomycin; Vancomycin Resistance

2009
Management of Clostridium difficile infection--medical or surgical?
    The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 2008, Volume: 6, Issue:6

    Topics: Anti-Bacterial Agents; Colectomy; Enterocolitis, Pseudomembranous; Humans; Vancomycin

2008
In vitro effect of metronidazole and vancomycin in combination on Clostridium difficile.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:5

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Drug Synergism; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Vancomycin

2009
Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Benzopyrans; Cell Line; Clostridioides difficile; Cricetinae; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Male; Spores, Bacterial; Survival Analysis; Thiophenes; Vancomycin

2009
[The approach to recurrent infections with Clostridium difficile].
    Harefuah, 2008, Volume: 147, Issue:11

    Topics: Anti-Bacterial Agents; Brachytherapy; Clostridioides difficile; Combined Modality Therapy; Complementary Therapies; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Metronidazole; Probiotics; Recurrence; Vancomycin

2008
Clostridium difficile-associated diarrhea in Crohn's disease patients with ostomy.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:1

    Topics: Adult; Clostridioides difficile; Colectomy; Crohn Disease; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Ostomy; Postoperative Complications; Prognosis; Vancomycin

2010
Working out the bug in the accordion.
    Gastroenterology, 2009, Volume: 137, Issue:1

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Colon; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Humans; Intestinal Mucosa; Male; Megacolon, Toxic; Middle Aged; Tomography, X-Ray Computed; Vancomycin

2009
Systemic absorption of oral vancomycin in a peripheral blood stem cell transplant patient with severe graft-versus-host disease of the gastrointestinal tract.
    Transplant infectious disease : an official journal of the Transplantation Society, 2009, Volume: 11, Issue:5

    Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Gastrointestinal Diseases; Gastrointestinal Tract; Graft vs Host Disease; Humans; Immunosuppressive Agents; Intestinal Absorption; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Vancomycin

2009
Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.
    Anaerobe, 2009, Volume: 15, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Agents; Humans; Male; Microbial Sensitivity Tests; Rifamycins; Rifaximin; Secondary Prevention; Treatment Outcome; Vancomycin

2009
Resolution of recurrent Clostridium difficile-associated diarrhea using staggered antibiotic withdrawal and kefir.
    Minnesota medicine, 2009, Volume: 92, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Cultured Milk Products; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Probiotics; Secondary Prevention; Vancomycin

2009
Clostridium difficile infection: historic review.
    Anaerobe, 2009, Volume: 15, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Female; Guinea Pigs; History, 20th Century; Humans; Metronidazole; Vancomycin; Young Adult

2009
Unexpected serum level of vancomycin after oral administration in a patient with severe colitis and renal insufficiency.
    International journal of clinical pharmacology and therapeutics, 2009, Volume: 47, Issue:11

    Topics: Acute Disease; Acute Kidney Injury; Administration, Oral; Aged; Anti-Bacterial Agents; Biological Availability; Drug Monitoring; Enterocolitis, Pseudomembranous; Hemodiafiltration; Humans; Male; Necrosis; Pancreatitis, Alcoholic; Severity of Illness Index; Vancomycin

2009
Fluoroquinolone resistance and Clostridium difficile, Germany.
    Emerging infectious diseases, 2010, Volume: 16, Issue:4

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Germany; Humans; Metronidazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Ribotyping; Vancomycin

2010
[Change of Clostridium difficile colitis during recent 10 years in Korea].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2010, Volume: 55, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Republic of Korea; Retrospective Studies; Vancomycin

2010
Clostridium difficile enteritis 9 years after total proctocolectomy: a rare case report.
    The American journal of gastroenterology, 2010, Volume: 105, Issue:4

    Topics: Anastomosis, Surgical; Anti-Bacterial Agents; Colitis, Ulcerative; Enteritis; Enterocolitis, Pseudomembranous; Female; Humans; Middle Aged; Proctocolectomy, Restorative; Vancomycin

2010
Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia.
    Nutritional neuroscience, 2010, Volume: 13, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Autistic Disorder; Child; Child, Preschool; Clostridioides difficile; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Tract; Humans; Male; Middle Aged; Phenylalanine; Phenylpropionates; Schizophrenia; Sex Characteristics; Vancomycin; Young Adult

2010
Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated Clostridium difficile infection.
    Infection control and hospital epidemiology, 2010, Volume: 31, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Disease Outbreaks; Enterococcus; Enterocolitis, Pseudomembranous; Female; Hospitals, University; Humans; Incidence; Male; Quebec; Vancomycin; Vancomycin Resistance

2010
Increase in use of vancomycin for Clostridium difficile infection in US hospitals.
    Infection control and hospital epidemiology, 2010, Volume: 31, Issue:8

    Topics: Academic Medical Centers; Adult; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; United States; Vancomycin; Young Adult

2010
Community-acquired Clostridium difficile-associated diarrhea in a patient on chronic peritoneal dialysis.
    Clinical nephrology, 2010, Volume: 74, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colonoscopy; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Peritoneal Dialysis; Vancomycin

2010
Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea.
    World journal of gastroenterology, 2010, Jul-28, Volume: 16, Issue:28

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Inpatients; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Vancomycin

2010
Failure of tigecycline to treat severe Clostridium difficile infection.
    Anaesthesia and intensive care, 2010, Volume: 38, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Critical Care; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Male; Metronidazole; Minocycline; Severity of Illness Index; Tigecycline; Treatment Failure; Vancomycin

2010
Oral vancomycin may have significant absorption in patients with Clostridium difficile colitis.
    Scandinavian journal of infectious diseases, 2011, Volume: 43, Issue:2

    Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Middle Aged; Serum; Vancomycin

2011
[A case of pseudomembranous colitis with febrile neutropenia induced by chemotherapy and effectively treated by vancomycin enemas].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:9

    Topics: Aged; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fever; Humans; Male; Neutropenia; Sigmoid Neoplasms; Vancomycin

2010
'Game changer' antibiotic and others in works for superbug.
    Nature medicine, 2011, Volume: 17, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Secondary Prevention; Streptococcal Infections; United States; United States Food and Drug Administration; Vancomycin

2011
Infection acquisition following intensive care unit room privatization.
    Archives of internal medicine, 2011, Jan-10, Volume: 171, Issue:1

    Topics: Clostridioides difficile; Cohort Studies; Critical Care; Drug Resistance, Bacterial; Enterococcus; Enterocolitis, Pseudomembranous; Hospital Design and Construction; Hospitals, University; Humans; Infection Control; Infections; Intensive Care Units; Interior Design and Furnishings; Methicillin-Resistant Staphylococcus aureus; Odds Ratio; Patients' Rooms; Quebec; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2011
Lack of health insurance coverage for oral vancomycin: it's time to tackle the elephant in the room.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Mar-01, Volume: 52, Issue:5

    Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Insurance, Pharmaceutical Services; Medicare; United States; Vancomycin

2011
Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population.
    Journal of pediatric gastroenterology and nutrition, 2011, Volume: 52, Issue:4

    Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Child; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Hospitals, Pediatric; Humans; Incidence; Inflammatory Bowel Diseases; Male; Metronidazole; Ohio; Retrospective Studies; Secondary Prevention; Vancomycin

2011
Epidemiology of clostridium difficile and vancomycin-resistant Enterococcus colonization in patients on a spinal cord injury unit.
    The journal of spinal cord medicine, 2011, Volume: 34, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; Carrier State; Clostridioides difficile; Enterococcus; Enterocolitis, Pseudomembranous; Humans; Middle Aged; Risk Factors; Spinal Cord Injuries; Urinary Tract Infections; Vancomycin; Vancomycin Resistance

2011
Imipenem-induced Clostridium difficile diarrhea in a patient with chronic renal failure.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2011, Volume: 22, Issue:3

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Imipenem; Kidney Failure, Chronic; Male; Pneumonia; Vancomycin

2011
Mouse relapse model of Clostridium difficile infection.
    Infection and immunity, 2011, Volume: 79, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Antibodies, Neutralizing; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Enterocolitis, Pseudomembranous; Enterotoxins; Mice; Mice, Inbred C57BL; Secondary Prevention; Vancomycin

2011
Risk factors for recurrence of Clostridium difficile infection: effect of vancomycin-resistant enterococci colonization.
    Journal of Korean medical science, 2011, Volume: 26, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Enterococcus; Enterocolitis, Pseudomembranous; Feces; Female; Hemoglobins; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Recurrence; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance

2011
Reversible bone marrow necrosis after all-trans retinoic acid induction therapy for acute promyelocytic leukaemia.
    Pathology, 2011, Volume: 43, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Enterocolitis, Pseudomembranous; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Necrosis; Recovery of Function; Remission Induction; Tretinoin; Vancomycin

2011
Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Volume: 53, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Male; Middle Aged; Vancomycin; Young Adult

2011
Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease.
    Annals of surgery, 2011, Volume: 254, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Colon; Enterocolitis, Pseudomembranous; Female; Humans; Ileostomy; Male; Middle Aged; Odds Ratio; Pennsylvania; Polyethylene Glycols; Retrospective Studies; Severity of Illness Index; Survival Rate; Therapeutic Irrigation; Vancomycin

2011
Reducing the risk of severe complications among patients with Clostridium difficile infection.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2011, Volume: 25, Issue:7

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiprotozoal Agents; Comorbidity; Confusion; Enterocolitis, Pseudomembranous; Female; Humans; Hypotension; Leukocytosis; Male; Metronidazole; Multivariate Analysis; Retrospective Studies; Severity of Illness Index; Vancomycin

2011
Antimicrobial use and risk for recurrent Clostridium difficile infection.
    The American journal of medicine, 2011, Volume: 124, Issue:11

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Hospitals, Veterans; Humans; Male; Metronidazole; Middle Aged; Minnesota; Recurrence; Retrospective Studies; Risk Factors; Vancomycin

2011
Recognizing metronidazole resistant C. difficile.
    The Nurse practitioner, 2011, Volume: 36, Issue:11

    Topics: Anti-Infective Agents; Clostridioides difficile; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Middle Aged; Opportunistic Infections; Probiotics; Recurrence; Vancomycin

2011
Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.
    Journal of Korean medical science, 2011, Volume: 26, Issue:10

    Topics: Aged; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Hospitals; Humans; Incidence; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Republic of Korea; Treatment Outcome; Vancomycin

2011
Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
    Scandinavian journal of infectious diseases, 2012, Volume: 44, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome; Vancomycin

2012
In vitro activities of CB-183,315, vancomycin, and metronidazole against 556 strains of Clostridium difficile, 445 other intestinal anaerobes, and 56 Enterobacteriaceae species.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Clostridioides difficile; Enterobacteriaceae; Enterobacteriaceae Infections; Enterocolitis, Pseudomembranous; Humans; Intestines; Lipopeptides; Metronidazole; Microbial Sensitivity Tests; Peptides, Cyclic; Vancomycin

2012
A novel agent effective against Clostridium difficile infection.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Disease Models, Animal; DNA-Directed DNA Polymerase; Enterocolitis, Pseudomembranous; Female; Humans; Morpholines; Nucleic Acid Synthesis Inhibitors; Purines; Vancomycin

2012
Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:4

    Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Data Interpretation, Statistical; Drug Therapy, Combination; Endpoint Determination; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Injections, Intravenous; Male; Metronidazole; Middle Aged; Poisson Distribution; Prospective Studies; Risk; Sex Factors; Treatment Outcome; Vancomycin; Young Adult

2012
Progress with a difficult infection.
    The Lancet. Infectious diseases, 2012, Volume: 12, Issue:4

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Male; Vancomycin

2012
A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs.
    Pharmacotherapy, 2012, Volume: 32, Issue:2

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Drug Evaluation; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Vancomycin

2012
Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.
    The American journal of gastroenterology, 2012, Volume: 107, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colonoscopy; Enterocolitis, Pseudomembranous; Feces; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Metagenome; Recurrence; Surveys and Questionnaires; United States; Vancomycin

2012
Evaluation of a hand-held far-ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens.
    BMC infectious diseases, 2012, May-16, Volume: 12

    Topics: Clostridioides difficile; Colony Count, Microbial; Cross Infection; Decontamination; Disinfection; Drug Resistance; Enterococcus; Enterocolitis, Pseudomembranous; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Ultraviolet Rays; Vancomycin

2012
A 5-year retrospective review of experience with Clostridium difficile-associated diarrhea.
    Military medicine, 2012, Volume: 177, Issue:4

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, Military; Humans; Incidence; Inpatients; Male; Medical Records Systems, Computerized; Metronidazole; Middle Aged; Military Medicine; Outpatients; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; United States; Vancomycin; Veterans

2012
Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Diarrhea; Endpoint Determination; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Polymers; Sulfonic Acids; Treatment Outcome; Vancomycin

2012
Efficacy of LFF571 in a hamster model of Clostridium difficile infection.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Cricetinae; Enterocolitis, Pseudomembranous; Enterotoxins; Male; Mesocricetus; Recurrence; Thiazoles; Vancomycin

2012
MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficile.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Clostridioides difficile; Cricetinae; DNA Gyrase; DNA Topoisomerases, Type I; DNA-Directed DNA Polymerase; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Metronidazole; Mice; Nucleic Acid Synthesis Inhibitors; Species Specificity; Survival Rate; Topoisomerase II Inhibitors; Vancomycin; Weight Gain

2012
In vitro and in vivo characterization of CB-183,315, a novel lipopeptide antibiotic for treatment of Clostridium difficile.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Enterocolitis, Pseudomembranous; Lipopeptides; Male; Mesocricetus; Microbial Sensitivity Tests; Peptides, Cyclic; Vancomycin

2012
[A case of pseudomembranous colitis concomitant with toxic megacolon and paralytic ileus].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2012, Volume: 109, Issue:8

    Topics: Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Intestinal Pseudo-Obstruction; Male; Megacolon, Toxic; Middle Aged; Vancomycin

2012
In vitro and in vivo activities of the novel Ketolide RBx 14255 against Clostridium difficile.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Ketolides; Metronidazole; Microbial Sensitivity Tests; Survival Rate; Vancomycin

2012
Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection.
    Infection, 2013, Volume: 41, Issue:2

    Topics: Administration, Oral; Adult; Anaphylaxis; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cystic Fibrosis; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Minocycline; Severity of Illness Index; Tigecycline; Vancomycin

2013
Fidaxomicin "chaser" regimen following vancomycin for patients with multiple Clostridium difficile recurrences.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Male; Recurrence; Treatment Outcome; Vancomycin

2013
[Clostridium difficile associated diarrhea: reliable therapy with vancomycin capsules].
    MMW Fortschritte der Medizin, 2012, Sep-24, Volume: 154, Issue:16

    Topics: Aged; Anti-Bacterial Agents; Capsules; Clostridioides difficile; Dysentery; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Risk Factors; Vancomycin

2012
Rifaximin in the treatment of recurrent Clostridium difficile infection.
    Alimentary pharmacology & therapeutics, 2013, Volume: 37, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Rifamycins; Rifaximin; Treatment Outcome; Vancomycin; Young Adult

2013
Pneumatosis intestinalis in a patient with recurrent Clostridium difficile infection.
    BMJ case reports, 2012, Oct-30, Volume: 2012

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colic; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Pneumatosis Cystoides Intestinalis; Recurrence; Tomography, X-Ray Computed; Vancomycin

2012
Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice.
    PLoS pathogens, 2012, Volume: 8, Issue:10

    Topics: Animals; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Feces; Female; Intestines; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Microbial Consortia; Microbial Interactions; Molecular Sequence Data; Probiotics; Recurrence; Vancomycin

2012
Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteroides; Cecum; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Intestines; Male; Metronidazole; Mice; Mice, Inbred C57BL; Nitro Compounds; Recurrence; Thiazoles; Treatment Outcome; Vancomycin

2013
[Role of Clostridium difficile infection in the relapse of ulcerative colitis].
    Anales de medicina interna (Madrid, Spain : 1984), 2002, Volume: 19, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colitis, Ulcerative; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Treatment Outcome; Vancomycin

2002
[Antibiotic-associated diarrhea].
    Deutsche medizinische Wochenschrift (1946), 2003, Feb-28, Volume: 128, Issue:9

    Topics: Anti-Bacterial Agents; Diarrhea; Enterocolitis, Pseudomembranous; Fluid Therapy; Humans; Metronidazole; Recurrence; Vancomycin

2003
Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2003, Volume: 9, Issue:1

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Child, Preschool; Clostridioides difficile; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Enterococcus faecium; Enterocolitis, Pseudomembranous; Female; Gram-Positive Bacterial Infections; Hospitals, Urban; Humans; Korea; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance

2003
Recurrent colitis with different causes.
    Journal of the American Geriatrics Society, 2003, Volume: 51, Issue:5

    Topics: Aged; Anti-Bacterial Agents; Cefpodoxime Proxetil; Ceftizoxime; Clostridioides difficile; Colitis, Ulcerative; Colonoscopy; Enterocolitis, Pseudomembranous; Female; Humans; Pharyngitis; Risk Factors; Sulfasalazine; Vancomycin

2003
Decompressive colonoscopy with intracolonic vancomycin administration for the treatment of severe pseudomembranous colitis.
    Surgical endoscopy, 2003, Volume: 17, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Colonoscopy; Decompression, Surgical; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Vancomycin

2003
Clostridium difficile infection in patients with unexplained leukocytosis.
    The American journal of medicine, 2003, Volume: 115, Issue:7

    Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Leukocytosis; Male; Metronidazole; Middle Aged; Prospective Studies; Vancomycin

2003
[Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002].
    Medycyna doswiadczalna i mikrobiologia, 2003, Volume: 55, Issue:3

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Vancomycin

2003
Clostridium difficile colitis in children with cystic fibrosis.
    Digestive diseases and sciences, 2004, Volume: 49, Issue:1

    Topics: Adolescent; Clostridioides difficile; Cystic Fibrosis; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Humans; Male; Tomography, X-Ray Computed; Vancomycin

2004
In-vitro activity of nisin against clinical isolates of Clostridium difficile.
    Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:2

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Nisin; Vancomycin

2004
Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2004, Volume: 6, Issue:1

    Topics: Adult; Aged; Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Kidney Transplantation; Male; Metronidazole; Middle Aged; Pancreas Transplantation; Risk Factors; Vancomycin

2004
Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Cecum; Clostridioides difficile; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Enzyme-Linked Immunosorbent Assay; Mesocricetus; Microbial Sensitivity Tests; Rifamycins; Secondary Prevention; Survival Analysis; Vancomycin; Weight Loss

2004
Pseudomembranous colitis.
    The Israel Medical Association journal : IMAJ, 2004, Volume: 6, Issue:10

    Topics: Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin

2004
Colostomy with vancomycin administration as an effective treatment for toxic megacolon associated with fulminant pseudomembranous colitis: a case report.
    Asian journal of surgery, 2004, Volume: 27, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Colostomy; Enterocolitis, Pseudomembranous; Female; Humans; Megacolon, Toxic; Vancomycin

2004
Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment.
    Reviews in gastroenterological disorders, 2004,Fall, Volume: 4, Issue:4

    Topics: Anti-Bacterial Agents; Diarrhea; Endoscopy, Gastrointestinal; Enterocolitis, Pseudomembranous; Feces; Humans; Immunoenzyme Techniques; Metronidazole; Recurrence; Risk Factors; Vancomycin

2004
Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jun-01, Volume: 40, Issue:11

    Topics: Anti-Bacterial Agents; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Follow-Up Studies; Humans; Metronidazole; Prospective Studies; Treatment Failure; Vancomycin

2005
Metronidazole for Clostridium difficile-associated disease: is it okay for Mom?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jun-01, Volume: 40, Issue:11

    Topics: Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin

2005
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jun-01, Volume: 40, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Enterocolitis, Pseudomembranous; Humans; Infant; Metronidazole; Middle Aged; Quebec; Recurrence; Risk Factors; Treatment Failure; Vancomycin

2005
Association of pseudomembranous colitis with Henoch-Schönlein purpura.
    Journal of gastroenterology, 2005, Volume: 40, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Biopsy; Clostridioides difficile; Colon; Colonoscopy; Enterocolitis, Pseudomembranous; Follow-Up Studies; Glucocorticoids; Humans; IgA Vasculitis; Male; Prednisolone; Vancomycin

2005
Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Cecum; Clindamycin; Clostridioides difficile; Cricetinae; Depsipeptides; Disease Models, Animal; Enterocolitis, Pseudomembranous; Gastrointestinal Contents; Male; Random Allocation; Time Factors; Vancomycin

2005
[Relapsing infections with Clostridium difficile].
    Nederlands tijdschrift voor geneeskunde, 2005, Oct-22, Volume: 149, Issue:43

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cytotoxins; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin

2005
Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.
    Bone marrow transplantation, 2006, Volume: 37, Issue:5

    Topics: Adult; Aged; Cephalosporins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Mobilization; Humans; Incidence; Lymphoma; Male; Middle Aged; Multiple Myeloma; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Risk Factors; Transplantation, Autologous; Vancomycin

2006
Severe diarrhea and shock.
    The Pediatric infectious disease journal, 2006, Volume: 25, Issue:3

    Topics: Adolescent; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Severity of Illness Index; Shock; Vancomycin

2006
[Pseudomembraneous colitis caused by a toxin B-positive and a toxin A-negative strain of Clostridium difficile].
    Ugeskrift for laeger, 2006, Apr-24, Volume: 168, Issue:17

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Colon; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Humans; Intestinal Mucosa; Vancomycin

2006
Significant absorption of oral vancomycin in a patient with clostridium difficile colitis and normal renal function.
    Southern medical journal, 2006, Volume: 99, Issue:5

    Topics: Absorption; Aged; Anti-Bacterial Agents; Colitis; Enterocolitis, Pseudomembranous; Female; Humans; Kidney; Vancomycin

2006
Vancomycin-induced elevation of liver enzyme levels.
    The Annals of pharmacotherapy, 2006, Volume: 40, Issue:6

    Topics: Alanine Transaminase; Anti-Bacterial Agents; Aspartate Aminotransferases; Clostridioides difficile; Diarrhea; Drug Resistance; Enterocolitis, Pseudomembranous; Humans; Liver; Liver Function Tests; Male; Metronidazole; Middle Aged; Vancomycin

2006
[Occurrence and treatment of Clostridium difficile-associated diarrhea].
    Ugeskrift for laeger, 2006, Jun-26, Volume: 168, Issue:26-32

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin

2006
Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2006, Sep-26, Volume: 175, Issue:7

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Community-Acquired Infections; Comorbidity; Databases, Factual; Drug Prescriptions; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Odds Ratio; Proton Pump Inhibitors; Risk Factors; United Kingdom; Vancomycin

2006
Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2006, Sep-26, Volume: 175, Issue:7

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Community-Acquired Infections; Drug Prescriptions; Enterocolitis, Pseudomembranous; Humans; Odds Ratio; Proton Pump Inhibitors; Risk Factors; United Kingdom; Vancomycin

2006
Management of an outbreak of Clostridium difficile-associated disease among geriatric patients.
    Infection control and hospital epidemiology, 2006, Volume: 27, Issue:11

    Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Feces; Female; Geriatrics; HeLa Cells; Hospital Units; Humans; Incidence; Infection Control; Male; Metronidazole; Saccharomyces; Treatment Outcome; Vancomycin

2006
Treatment of Clostridium difficile-associated disease (CDAD).
    The Medical letter on drugs and therapeutics, 2006, Nov-06, Volume: 48, Issue:1247

    Topics: Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin

2006
New PCR ribotypes of Clostridium difficile detected in children in Brazil: prevalent types of Clostridium difficile in Brazil.
    Antonie van Leeuwenhoek, 2007, Volume: 92, Issue:1

    Topics: Brazil; Child; Child, Preschool; Clindamycin; Clostridioides difficile; Electrophoresis, Polyacrylamide Gel; Enterocolitis, Pseudomembranous; Humans; Infant; Metronidazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Ribotyping; Vancomycin

2007
Effects of combination therapy with direct hemoperfusion using polymyxin B-immobilized fiber and oral vancomycin on fulminant pseudomembranous colitis with septic shock.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:3

    Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Combined Modality Therapy; Disease Progression; Enterocolitis, Pseudomembranous; Hemoperfusion; Humans; Male; Middle Aged; Polymyxin B; Shock, Septic; Vancomycin

2007
Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Mar-15, Volume: 44, Issue:6

    Topics: Adult; Age Factors; Aged; Clostridioides difficile; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rifamycins; Rifaximin; Risk Factors; Secondary Prevention; Severity of Illness Index; Treatment Outcome; Vancomycin

2007
[Clostridium difficile associated diarrhea in the elderly patient].
    Revista clinica espanola, 2007, Volume: 207, Issue:2

    Topics: Age Factors; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin

2007
Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis.
    The American journal of geriatric pharmacotherapy, 2007, Volume: 5, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Carcinoma, Merkel Cell; Clostridioides difficile; Cytotoxins; Diarrhea; Ear Neoplasms; Enterocolitis, Pseudomembranous; Esomeprazole; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Levofloxacin; Male; Metronidazole; Ofloxacin; Skin Neoplasms; Thyroxine; Vancomycin

2007
A case of recurrent Clostridium difficile diarrhea.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2007, Volume: 22, Issue:3

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Lactobacillus; Metronidazole; Probiotics; Recurrence; Treatment Failure; Vancomycin

2007
Epidemiology of Clostridium difficile infection in a large teaching hospital in Singapore.
    Pathology, 2007, Volume: 39, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Hospitals, Teaching; Humans; Incidence; Male; Metronidazole; Middle Aged; Ribotyping; RNA, Bacterial; Singapore; Vancomycin

2007
Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    The American journal of gastroenterology, 2007, Volume: 102, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Chi-Square Distribution; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Logistic Models; Male; Metronidazole; Quebec; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Outcome; Vancomycin

2007
The changing face of Clostridium difficile: what treatment options remain?
    The American journal of gastroenterology, 2007, Volume: 102, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Quebec; Recurrence; Risk Factors; Severity of Illness Index; Treatment Outcome; Vancomycin

2007
Clostridium difficile-associated disease with lethal outcome in a 77-year-old woman. A case report.
    Minerva gastroenterologica e dietologica, 2007, Volume: 53, Issue:4

    Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Cholecystitis; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Famotidine; Female; Humans; Metronidazole; Postoperative Complications; Vancomycin

2007
Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, May-15, Volume: 46, Issue:10

    Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Europe; Humans; Metronidazole; North America; Vancomycin

2008
Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Administration, Oral; Aged; Aged, 80 and over; Clostridioides difficile; Cross Infection; Enterococcus; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Vancomycin; Vancomycin Resistance

2008
Clostridium difficile infection.
    Lancet (London, England), 2008, May-03, Volume: 371, Issue:9623

    Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Infant, Newborn; Metronidazole; Risk Factors; Vancomycin

2008
Vancomycin-resistant Enterococcus faecium meningitis successfully treated with linezolid.
    Southern medical journal, 2008, Volume: 101, Issue:5

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Humans; Male; Meningitis, Bacterial; Vancomycin

2008
Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Jul-01, Volume: 47, Issue:1

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Treatment Outcome; Vancomycin

2008
Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Jul-01, Volume: 47, Issue:1

    Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Colony Count, Microbial; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Kaplan-Meier Estimate; Metronidazole; Middle Aged; Proportional Hazards Models; Prospective Studies; Time Factors; Treatment Outcome; Vancomycin

2008
[Postpartum pseudomembranous colitis].
    Der Internist, 1984, Volume: 25, Issue:12

    Topics: Adult; Cefotaxime; Colon; Colonoscopy; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Gentamicins; Humans; Hysterectomy; Methylmethacrylates; Metronidazole; Obstetric Labor Complications; Pregnancy; Puerperal Disorders; Shock; Uterine Hemorrhage; Vancomycin

1984
Vancomycin dose for pseudomembranous colitis.
    Lancet (London, England), 1980, Jul-26, Volume: 2, Issue:8187

    Topics: Aged; Clostridium; Enterocolitis, Pseudomembranous; Female; Humans; Vancomycin

1980
Vancomycin dose for pseudomembranous colitis.
    Lancet (London, England), 1980, Aug-23, Volume: 2, Issue:8191

    Topics: Costs and Cost Analysis; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin

1980
Ampicillin-induced enterocolitis: implication of toxigenic Clostridium perfringens type C.
    The Journal of pediatrics, 1980, Volume: 97, Issue:4

    Topics: Ampicillin; Bacterial Toxins; Child; Clostridium Infections; Clostridium perfringens; Enterocolitis, Pseudomembranous; Humans; Male; Vancomycin

1980
Is vancomycin overpriced?
    The New England journal of medicine, 1983, Jun-23, Volume: 308, Issue:25

    Topics: Anti-Bacterial Agents; Cost-Benefit Analysis; Costs and Cost Analysis; Enterocolitis, Pseudomembranous; Humans; Vancomycin

1983
Pseudomembranous colitis after topical application of clindamycin.
    Archives of dermatology, 1981, Volume: 117, Issue:3

    Topics: Acne Vulgaris; Administration, Topical; Adult; Clindamycin; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Vancomycin

1981
Treatment of antibiotic-associated colitis with vancomycin.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 14 Suppl D

    Topics: Adult; Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; Bacterial Toxins; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Infant; Metronidazole; Vancomycin

1984
Spontaneous pseudomembranous colitis.
    The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 1983, Volume: 135, Issue:10

    Topics: Enterocolitis, Pseudomembranous; Female; Humans; Middle Aged; Vancomycin

1983
Acute oligoarthritis associated with Clostridium difficile pseudomembranous colitis.
    Archives of internal medicine, 1984, Volume: 144, Issue:3

    Topics: Adult; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; HLA Antigens; HLA-B27 Antigen; Humans; Male; Middle Aged; Osteoarthritis; Vancomycin

1984
[Clostridium difficile].
    Zeitschrift fur arztliche Fortbildung, 1983, Volume: 77, Issue:24

    Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Toxins, Biological; Vancomycin

1983
Pseudomembranous colitis with recurring diarrhoea and prolonged persistence of Clostridium difficile in a 10-year-old girl.
    Acta paediatrica Scandinavica, 1984, Volume: 73, Issue:1

    Topics: Amoxicillin; Carrier State; Child; Clostridium; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Recurrence; Vancomycin

1984
Systemic absorption of enteral vancomycin in a patient with pseudomembranous colitis.
    Annals of internal medicine, 1984, Volume: 100, Issue:4

    Topics: Anuria; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Intestinal Absorption; Kidney; Male; Middle Aged; Vancomycin

1984
Pseudomembranous colitis due to oxacillin therapy.
    Southern medical journal, 1984, Volume: 77, Issue:4

    Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Middle Aged; Oxacillin; Vancomycin

1984
Fatal pseudomembranous colitis despite eradication of Clostridium difficile.
    British medical journal (Clinical research ed.), 1981, Jan-10, Volume: 282, Issue:6258

    Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Vancomycin

1981
Antibiotic-associated colitis--the continuing saga.
    British medical journal (Clinical research ed.), 1981, Jun-13, Volume: 282, Issue:6280

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Vancomycin

1981
Non-Clostridium difficile pseudomembranous colitis responding to both vancomycin and metronidazole. ?
    British medical journal (Clinical research ed.), 1981, Sep-26, Volume: 283, Issue:6295

    Topics: Adolescent; Clostridium; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Vancomycin

1981
Metronidazole and antibiotic-associated colitis.
    British medical journal (Clinical research ed.), 1981, Nov-14, Volume: 283, Issue:6302

    Topics: Aged; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Vancomycin

1981
Antibiotic-associated pseudomembranous colitis.
    Hospital practice (Office ed.), 1981, Volume: 16, Issue:12

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacitracin; Cephalosporins; Cholestyramine Resin; Clindamycin; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Guinea Pigs; Humans; Intestines; Staphylococcal Infections; Vancomycin

1981
Vancomycin: a reappraisal.
    British medical journal (Clinical research ed.), 1982, May-22, Volume: 284, Issue:6328

    Topics: Clostridium Infections; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterocolitis, Pseudomembranous; Humans; Staphylococcal Infections; Streptococcal Infections; Vancomycin

1982
Spontaneous persistent pseudomembranous colitis related to Clostridium difficile in ischaemic bowel disease.
    British medical journal (Clinical research ed.), 1982, May-29, Volume: 284, Issue:6329

    Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Intestines; Ischemia; Vancomycin

1982
Absorption of oral vancomycin - possible associated toxicity.
    The International journal of pediatric nephrology, 1983, Volume: 4, Issue:1

    Topics: Administration, Oral; Adolescent; Brain Diseases; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Fever; Humans; Vancomycin

1983
An outbreak of Clostridium difficile necrotizing enterocolitis: a case for oral vancomycin therapy?
    Pediatrics, 1983, Volume: 71, Issue:6

    Topics: Clostridium Infections; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Vancomycin

1983
Antibiotic-associated diarrhoea and pseudomembranous colitis caused by Clostridium difficile. A review of 40 cases.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1983, Jun-11, Volume: 63, Issue:24

    Topics: Adult; Clostridium; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Vancomycin

1983
Bacitracin therapy in antibiotic-associated pseudomembranous colitis.
    Digestive diseases and sciences, 1980, Volume: 25, Issue:10

    Topics: Adult; Ampicillin; Bacitracin; Cephalosporins; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Male; Penicillin Resistance; Urinary Tract Infections; Vancomycin

1980
[Pseudomembranous colitis: observations on 13 clinical cases].
    Giornale di clinica medica, 1981, Volume: 62, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; Drug Combinations; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Loperamide; Male; Metronidazole; Middle Aged; Neomycin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

1981
Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.
    Gastroenterology, 1980, Volume: 78, Issue:3

    Topics: Anti-Bacterial Agents; Clostridium; Clostridium Infections; Cytotoxins; Enterocolitis, Pseudomembranous; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Recurrence; Vancomycin

1980
Antibiotic-associated pseudomembranous colitis: 1980.
    Comprehensive therapy, 1980, Volume: 6, Issue:1

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cholestyramine Resin; Clindamycin; Clostridium; Cricetinae; Enterocolitis, Pseudomembranous; Humans; Vancomycin

1980
Metronidazole: an alternate therapy for antibiotic-associated colitis.
    Gastroenterology, 1982, Volume: 82, Issue:5 Pt 1

    Topics: Adult; Aged; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Vancomycin

1982
Treatment of recurrent antibiotic-associated pseudomembranous colitis.
    The American journal of gastroenterology, 1982, Volume: 77, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Recurrence; Vancomycin

1982
[Vancomycin: treatment of staphylococcal septicemias and pseudomembranous colitis].
    Medecine & chirurgie digestives, 1982, Volume: 11, Issue:3

    Topics: Enterocolitis, Pseudomembranous; Humans; Sepsis; Staphylococcal Infections; Vancomycin

1982
Pseudomembranous colitis unresponsive to oral vancomycin therapy.
    Southern medical journal, 1982, Volume: 75, Issue:10

    Topics: Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Middle Aged; Vancomycin

1982
Diarrhea we can treat: antibiotic-associated colitis.
    Comprehensive therapy, 1982, Volume: 8, Issue:8

    Topics: Anti-Bacterial Agents; Clostridium Infections; Colitis; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Vancomycin

1982
Clostridium difficile: the epidemiology and prevention of hospital-acquired infection.
    Infection, 1982, Volume: 10, Issue:4

    Topics: Anti-Bacterial Agents; Clostridium; Clostridium Infections; Cross Infection; Disinfection; Enterocolitis, Pseudomembranous; Equipment and Supplies, Hospital; Feces; Humans; Vancomycin

1982
Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis.
    Infection, 1982, Volume: 10, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Child; Clostridium; Clostridium Infections; Cytotoxins; Enterocolitis, Pseudomembranous; Feces; Humans; Middle Aged; Vancomycin

1982
Recurrence of antibiotic-associated pseudomembranous colitis after parenteral metronidazole therapy and cure by oral vancomycin: case report.
    The Netherlands journal of medicine, 1981, Volume: 24, Issue:1

    Topics: Administration, Oral; Aged; Enterocolitis, Pseudomembranous; Humans; Injections, Intravenous; Male; Metronidazole; Recurrence; Vancomycin

1981
Pseudomembranous colitis.
    Scottish medical journal, 1980, Volume: 25, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Female; Humans; Middle Aged; Vancomycin

1980
Case report. Clindamycin associated pseudomembranous colitis.
    Acta paediatrica Scandinavica, 1981, Volume: 70, Issue:1

    Topics: Child; Clindamycin; Clostridium; Enterocolitis, Pseudomembranous; Humans; Male; Vancomycin

1981
A second relapse of Clostridium difficile colitis.
    The Journal of antimicrobial chemotherapy, 1981, Volume: 7, Issue:2

    Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin

1981
Studies on the epidemiology of colitis due to Clostridium difficile in hamsters.
    The Journal of infectious diseases, 1981, Volume: 143, Issue:1

    Topics: Animals; Clostridium; Clostridium Infections; Colitis; Cricetinae; Cross Infection; Disinfection; Enterocolitis, Pseudomembranous; Mesocricetus; Vancomycin

1981
Recurrent pseudomembranous colitis unassociated with prior antibiotic therapy.
    Archives of internal medicine, 1981, Volume: 141, Issue:5

    Topics: Aged; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Recurrence; Vancomycin

1981
Antibiotic-associated pseudomembranous colitis in children.
    Pediatrics, 1981, Volume: 67, Issue:3

    Topics: Administration, Oral; Adolescent; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Cholestyramine Resin; Clindamycin; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Infant; Male; Penicillin G; Vancomycin

1981
Pseudomembranous colitis: multiple relapses after treatment with metronidazole.
    Canadian Medical Association journal, 1981, Jun-15, Volume: 124, Issue:12

    Topics: Aged; Cholestyramine Resin; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Metronidazole; Recurrence; Vancomycin

1981
Survival after necrotizing enterocolitis of leukemia treated with oral vancomycin.
    Gastroenterology, 1981, Volume: 81, Issue:4

    Topics: Administration, Oral; Enterocolitis, Pseudomembranous; Female; Humans; Leukemia, Lymphoid; Middle Aged; Vancomycin

1981
Antibiotic-associated colitis--an abating enigma.
    Journal of clinical gastroenterology, 1981, Volume: 3, Issue:3

    Topics: Anti-Bacterial Agents; Bacitracin; Clindamycin; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Lincomycin; Metronidazole; Vancomycin

1981
Nonantibiotic-associated enterocolitis caused by Clostridium difficile in an infant.
    The Journal of pediatrics, 1981, Volume: 99, Issue:5

    Topics: Biopsy; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Infant; Jejunum; Vancomycin

1981
Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins.
    The Journal of infectious diseases, 1980, Volume: 141, Issue:1

    Topics: Absorption; Animals; Anion Exchange Resins; Anti-Bacterial Agents; Binding, Competitive; Cholestyramine Resin; Clindamycin; Clostridium; Colestipol; Cricetinae; Cytotoxins; Disease Models, Animal; Dose-Response Relationship, Drug; Enterocolitis, Pseudomembranous; Feces; Ion Exchange Resins; Male; Vancomycin

1980
The response of pseudomembranous colitis to vancomycin.
    The Central African journal of medicine, 1980, Volume: 26, Issue:2

    Topics: Enterocolitis, Pseudomembranous; Humans; Vancomycin

1980
Bacitracin treatment of antibiotic-associated colitis and diarrhea caused by Clostridium difficile toxin.
    Gastroenterology, 1980, Volume: 78, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Bacitracin; Bacterial Toxins; Clostridium; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Middle Aged; Recurrence; Vancomycin

1980
Non-antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia.
    Annals of internal medicine, 1980, Volume: 92, Issue:6

    Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Vancomycin

1980
Relapse of antibiotic-associated colitis after vancomycin therapy.
    The Medical journal of Australia, 1980, Apr-05, Volume: 1, Issue:7

    Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin

1980
Antibiotic-associated pseudomembranous colitis: pathogenesis and management.
    Drugs, 1980, Volume: 20, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridium; England; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Prospective Studies; Vancomycin

1980
Treatment and prevention of antimicrobial agent-induced colitis and diarrhae.
    Gastroenterology, 1980, Volume: 79, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacitracin; Cholestyramine Resin; Clostridium Infections; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Rabbits; Vancomycin

1980
Antibiotic-induced colitis.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1980, Jan-26, Volume: 57, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Vancomycin

1980
Oxacillin-induced pseudomembranous colitis.
    The American journal of gastroenterology, 1980, Volume: 73, Issue:5

    Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Oxacillin; Staphylococcal Infections; Vancomycin

1980
Vancomycin therapy for Clostridium difficile.
    The Medical journal of Australia, 1980, Jul-26, Volume: 2, Issue:2

    Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Recurrence; Vancomycin

1980
Vancomycin therapy Clostridium difficile.
    The Medical journal of Australia, 1980, Jul-26, Volume: 2, Issue:2

    Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin

1980
Relapse of Clostridium colitis after vancomycin therapy.
    The Journal of antimicrobial chemotherapy, 1980, Volume: 6, Issue:4

    Topics: Adult; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin

1980
[Carcinoembryonic antigen in a case of pseudomembraneous colitis].
    La Nouvelle presse medicale, 1980, Oct-11, Volume: 9, Issue:37

    Topics: Aged; Carcinoembryonic Antigen; Enterocolitis, Pseudomembranous; Female; Humans; Vancomycin

1980
Studies on the epidemiology of antibiotic-associated Clostridium difficile colitis.
    The American journal of clinical nutrition, 1980, Volume: 33, Issue:11 Suppl

    Topics: Animals; Anti-Bacterial Agents; Cecal Diseases; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Feces; Humans; Inflammation; Intestines; Male; Patient Isolation; Vancomycin

1980
Clinical and laboratory observations in Clostridium difficile colitis.
    The American journal of clinical nutrition, 1980, Volume: 33, Issue:11 Suppl

    Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Cholestyramine Resin; Clostridium; Cricetinae; Cytotoxins; Disease Models, Animal; Enterocolitis, Pseudomembranous; Guinea Pigs; Vancomycin

1980
[Antibiotic-induced pseudomembranous colitis].
    Lakartidningen, 1980, Jul-23, Volume: 77, Issue:30-31

    Topics: Aged; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Female; Humans; Vancomycin

1980
[Peroral vancomycin for antibiotic-related pseudomembraneous colitis].
    Ugeskrift for laeger, 1980, Nov-10, Volume: 142, Issue:46

    Topics: Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Vancomycin

1980
[Pseudomembranous entercolitis after antibiotic treatment: vancomycin therapy].
    Helvetica paediatrica acta, 1980, Volume: 35, Issue:4

    Topics: Amoxicillin; Child, Preschool; Enterocolitis, Pseudomembranous; Humans; Male; Otitis Media; Vancomycin

1980
Treatment of pseudomembranous colitis with oral metronidazole after relapse following vancomycin.
    The American journal of gastroenterology, 1980, Volume: 74, Issue:4

    Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Middle Aged; Vancomycin

1980
Vancomycin pharmacokinetics and dosing in premature neonates.
    Therapeutic drug monitoring, 1995, Volume: 17, Issue:4

    Topics: Anti-Bacterial Agents; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Humans; Infant, Newborn; Infant, Premature, Diseases; Infusions, Intravenous; Sepsis; Staphylococcal Infections; Vancomycin

1995
Baker's yeast as adjunctive therapy for relapses of Clostridium difficile diarrhea.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 20, Issue:6

    Topics: Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Recurrence; Saccharomyces cerevisiae; Vancomycin

1995
Systemic absorption of vancomycin.
    Journal of clinical pathology, 1995, Volume: 48, Issue:7

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Enterocolitis, Pseudomembranous; Humans; Intestinal Absorption; Middle Aged; Vancomycin

1995
[Pseudomembranous colitis probably caused by Clostridium difficile: first case appeared during preventive treatment of infection of ascitic fluid with norfloxacin].
    Gastroenterologie clinique et biologique, 1995, Volume: 19, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ascitic Fluid; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Norfloxacin; Vancomycin

1995
[5 cases of clostridium difficile enteritis in infants].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1995, Volume: 69, Issue:5

    Topics: Child; Child, Preschool; Enterocolitis, Pseudomembranous; Erythromycin; Female; Humans; Male; Prognosis; Vancomycin

1995
Pseudomembranous colitis in a patient with a colostomy.
    Israel journal of medical sciences, 1995, Volume: 31, Issue:6

    Topics: Cephalexin; Colonoscopy; Colostomy; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Middle Aged; Urinary Tract Infections; Vancomycin

1995
Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991.
    Infection control and hospital epidemiology, 1994, Volume: 15, Issue:6

    Topics: Administration, Oral; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Feces; Hospitals, Veterans; Humans; Metronidazole; Minnesota; Population Surveillance; Prospective Studies; Vancomycin

1994
[Combatting nosocomial intestinal infections with yeasts].
    Fortschritte der Medizin, 1995, Feb-20, Volume: 113, Issue:5

    Topics: Combined Modality Therapy; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Saccharomyces; Vancomycin; Yeast, Dried

1995
Clostridium difficile colitis: an increasing hospital-acquired illness.
    American journal of surgery, 1995, Volume: 169, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cholestyramine Resin; Cross Infection; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Hospital Mortality; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Metronidazole; Middle Aged; Premedication; Retrospective Studies; Surgical Procedures, Operative; Survival Rate; Vancomycin

1995
Cefixime and antibiotic-associated colitis.
    The Pediatric infectious disease journal, 1994, Volume: 13, Issue:4

    Topics: Cefixime; Cefotaxime; Child; Child, Preschool; Enterocolitis, Pseudomembranous; Female; Humans; Male; Vancomycin

1994
[Clostridium difficile in early childhood ulcerative pancolitis].
    Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1993, Volume: 141, Issue:6

    Topics: Biopsy; Colitis, Ulcerative; Enterocolitis, Pseudomembranous; Humans; Infant; Intestinal Mucosa; Male; Prednisone; Recurrence; Sulfasalazine; Vancomycin

1993
Systemic absorption after local intracolonic vancomycin in pseudomembranous colitis.
    Lancet (London, England), 1993, Aug-14, Volume: 342, Issue:8868

    Topics: Acute Kidney Injury; Enterocolitis, Pseudomembranous; Hemofiltration; Humans; Intestinal Absorption; Vancomycin

1993
Clostridium difficile colitis.
    The New England journal of medicine, 1994, Jun-16, Volume: 330, Issue:24

    Topics: Aged; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin

1994
Clostridium difficile colitis.
    The New England journal of medicine, 1994, Jun-16, Volume: 330, Issue:24

    Topics: Clostridioides difficile; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Humans; Risk Factors; Vancomycin

1994
Clostridium difficile after haemolytic uraemic syndrome.
    Archives of disease in childhood, 1993, Volume: 69, Issue:2

    Topics: Adolescent; Child; Child, Preschool; Clostridioides difficile; Enterocolitis, Pseudomembranous; Escherichia coli Infections; Female; Hemolytic-Uremic Syndrome; Humans; Male; Vancomycin

1993
Intracolonic vancomycin for pseudomembranous colitis.
    The New England journal of medicine, 1993, Aug-19, Volume: 329, Issue:8

    Topics: Aged; Aged, 80 and over; Enterocolitis, Pseudomembranous; Humans; Intestinal Pseudo-Obstruction; Intubation, Gastrointestinal; Male; Vancomycin

1993
Antibiotic-associated pseudomembranous colitis with toxic megacolon after cesarean section.
    Journal of the Tennessee Medical Association, 1993, Volume: 86, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Cesarean Section; Enterocolitis, Pseudomembranous; Female; Humans; Megacolon, Toxic; Postoperative Complications; Vancomycin

1993
Clostridium difficile infection is a treatable cause of diarrhea in patients with advanced human immunodeficiency virus infection: a study of seven consecutive patients admitted from 1986 to 1992 to a university teaching hospital.
    The American journal of gastroenterology, 1993, Volume: 88, Issue:6

    Topics: Adult; AIDS-Related Opportunistic Infections; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Humans; Male; Metronidazole; Vancomycin

1993
Clostridium difficile diarrhea in patients with AIDS versus non-AIDS controls. Methods of treatment and clinical response to treatment.
    Journal of clinical gastroenterology, 1993, Volume: 16, Issue:3

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bacterial Toxins; Case-Control Studies; Chi-Square Distribution; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Leukocyte Count; Male; Metronidazole; Vancomycin

1993
[Toxic megacolon in pseudomembranous colitis. Complicated course of antibiotic-induced Clostridium difficile colitis].
    Fortschritte der Medizin, 1993, May-10, Volume: 111, Issue:13

    Topics: Adolescent; Clindamycin; Combined Modality Therapy; Enterocolitis, Pseudomembranous; Fluid Therapy; Humans; Male; Megacolon, Toxic; Sigmoidoscopy; Sinusitis; Vancomycin

1993
Vancomycin-dependent Enterococcus faecium isolated from stool following oral vancomycin therapy.
    Journal of clinical microbiology, 1995, Volume: 33, Issue:10

    Topics: Aged; Aged, 80 and over; DNA, Bacterial; Enterococcus faecium; Enterocolitis, Pseudomembranous; Feces; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Vancomycin

1995
The clinical spectrum of Clostridium difficile colitis in immunocompromised patients.
    The American surgeon, 1996, Volume: 62, Issue:7

    Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Immunocompromised Host; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin

1996
Acute flexor tenosynovitis in association with Clostridium difficile infection: a case report.
    The Journal of hand surgery, 1996, Volume: 21, Issue:2

    Topics: Adult; Amoxicillin; Arthritis, Infectious; Clostridioides difficile; Combined Modality Therapy; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Infant, Newborn; Otitis Media; Pregnancy; Pregnancy Complications, Infectious; Quadriplegia; Tenosynovitis; Vancomycin

1996
Relapses or reinfections: analysis of a case of Clostridium difficile-associated colitis by two typing systems.
    Current microbiology, 1996, Volume: 33, Issue:4

    Topics: Anti-Bacterial Agents; Child; Clostridioides difficile; DNA, Bacterial; Electrophoresis, Polyacrylamide Gel; Enterocolitis, Pseudomembranous; Female; Humans; Immunoblotting; Recurrence; Vancomycin

1996
[Occurrence and clinical picture of Clostridium difficile infections after antibiotic therapy].
    Przeglad epidemiologiczny, 1995, Volume: 49, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Cholestyramine Resin; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Vancomycin

1995
Pseudomembranous colitis.
    The Journal of the Arkansas Medical Society, 1996, Volume: 93, Issue:7

    Topics: Administration, Oral; Anti-Infective Agents; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin

1996
[A case of pseudomembranous enterocolitis which diagnosis was delayed in the outpatient clinic].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1997, Volume: 71, Issue:1

    Topics: Aged; Ambulatory Care; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Male; Vancomycin

1997
Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25 Suppl 2

    Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Humans; Metronidazole; Vancomycin

1997
[Complicated amebic liver abscess--course and therapy].
    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 1997, Volume: 32, Issue:8

    Topics: Combined Modality Therapy; Cytomegalovirus Infections; Enterocolitis, Pseudomembranous; Escherichia coli Infections; Escherichia coli O157; Feces; Gastrointestinal Hemorrhage; Humans; Liver Abscess, Amebic; Male; Middle Aged; Opportunistic Infections; Postoperative Complications; Pulmonary Atelectasis; Respiratory Insufficiency; Tomography, X-Ray Computed; Travel; Vancomycin

1997
Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:5

    Topics: Acute Disease; Bacteremia; Clostridioides difficile; Cohort Studies; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Leukemia; Male; Middle Aged; Neutropenia; Risk Factors; Vancomycin

1997
Fulminant pseudomembranous colitis leading to total colonic stricture.
    JPMA. The Journal of the Pakistan Medical Association, 1997, Volume: 47, Issue:11

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Child; Colectomy; Colonic Diseases; Constriction, Pathologic; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Ileostomy; Metronidazole; Proctocolectomy, Restorative; Rectal Diseases; Vancomycin

1997
Pseudomembraneous clostridium after autologous bone marrow transplantation.
    Bone marrow transplantation, 1998, Volume: 21, Issue:5

    Topics: Adolescent; Anti-Bacterial Agents; Antitrichomonal Agents; Bone Marrow Transplantation; Clostridioides difficile; Enterocolitis, Pseudomembranous; Hematopoiesis; Hodgkin Disease; Humans; Male; Metronidazole; Transplantation, Autologous; Vancomycin

1998
[Clostridium difficile toxin-associated diarrhea in geriatrics].
    Zeitschrift fur Gerontologie und Geriatrie, 1998, Volume: 31, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Frail Elderly; Humans; Male; Risk Factors; Vancomycin

1998
Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers.
    Infection control and hospital epidemiology, 1998, Volume: 19, Issue:5

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 300 to 499; Hospitals, Community; Humans; Incidence; Poisson Distribution; Thermometers; United States; Vancomycin

1998
Clostridium difficile colitis: factors influencing treatment failure and relapse--a prospective evaluation.
    The American journal of gastroenterology, 1998, Volume: 93, Issue:10

    Topics: Aged; Anti-Bacterial Agents; Case-Control Studies; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Linear Models; Male; Metronidazole; Prospective Studies; Recurrence; Risk Factors; Serum Albumin; Time Factors; Treatment Failure; Vancomycin

1998
Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest.
    Diagnostic microbiology and infectious disease, 1999, Volume: 34, Issue:1

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Prospective Studies; Vancomycin

1999
The hunt for Clostridium difficile: 21-year follow-up of a stool specimen sent for culture.
    Lancet (London, England), 1999, Sep-25, Volume: 354, Issue:9184

    Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Penicillins; Vancomycin

1999
Clostridium difficile splenic abscess.
    The Australian and New Zealand journal of surgery, 2000, Volume: 70, Issue:2

    Topics: Abscess; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Injections, Intravenous; Male; Middle Aged; Splenic Diseases; Vancomycin

2000
Systemic vancomycin overexposure in a patient with spinal cord injury who had Staphylococcal sepsis and Clostridium difficile colitis.
    Therapeutic drug monitoring, 2000, Volume: 22, Issue:2

    Topics: Anti-Bacterial Agents; Bacteremia; Drug Monitoring; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Spinal Cord Injuries; Staphylococcal Infections; Vancomycin

2000
In vitro and in vivo activities of nitazoxanide against Clostridium difficile.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Metronidazole; Microbial Sensitivity Tests; Nitro Compounds; Thiazoles; Vancomycin

2000
[Recurrent Clostridium difficile enterocolitis].
    Schweizerische medizinische Wochenschrift, 2000, Nov-04, Volume: 130, Issue:44

    Topics: Aged; Aged, 80 and over; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Immunoglobulins, Intravenous; Metronidazole; Recurrence; Saccharomyces; Vancomycin

2000
Clinical microbiological case: a heart transplant recipient with diarrhea and abdominal pain. Recurring C. difficile infection.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2001, Volume: 7, Issue:8

    Topics: Abdominal Pain; Adult; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Graft Rejection; Heart Transplantation; Humans; Immunocompromised Host; Male; Metronidazole; Vancomycin

2001
Decompressive colonoscopy with intracolonic vancomycin administration for the treatment of severe pseudomembranous colitis.
    Surgical endoscopy, 2001, Volume: 15, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Colonoscopy; Decompression, Surgical; Enterocolitis, Pseudomembranous; Feasibility Studies; Humans; Instillation, Drug; Male; Middle Aged; Treatment Outcome; Vancomycin

2001
Intracolonic use of vancomycin for treatment of clostridium difficile colitis in a patient with a diverted colon: report of a case.
    Diseases of the colon and rectum, 2001, Volume: 44, Issue:12

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diverticulum, Colon; Enema; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Vancomycin

2001
Severe antibiotic-associated colitis in a patient with cystic fibrosis and colonic wall thickening.
    Journal of pediatric gastroenterology and nutrition, 2002, Volume: 34, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Colon; Cystic Fibrosis; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Metronidazole; Recurrence; Tomography, X-Ray Computed; Ultrasonography; Vancomycin

2002
Severe Clostridium difficile colitis: the role of intracolonic vancomycin?
    The American journal of medicine, 2002, Volume: 112, Issue:4

    Topics: Administration, Rectal; Adult; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Female; Humans; Immunocompromised Host; Opportunistic Infections; Vancomycin

2002
Incidence of pseudomembranous colitis after vancomycin-treated MRSA infection.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2002, Volume: 8, Issue:1

    Topics: Brain Neoplasms; Clostridioides difficile; Critical Care; Enterocolitis, Pseudomembranous; Fatal Outcome; Humans; Incidence; Male; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections; Vancomycin

2002
Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; HIV Infections; Humans; Metronidazole; Microbial Sensitivity Tests; Time Factors; Vancomycin

2002
Value of Clostridium difficile antigen test in immunocompromised hosts in the tropics.
    Journal of chemotherapy (Florence, Italy), 1991, Volume: 3 Suppl 1

    Topics: Anti-Bacterial Agents; Antigens, Bacterial; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Immunocompromised Host; Tropical Climate; Vancomycin

1991
Vancomycin for antibiotic-induced colitis.
    Lancet (London, England), 1978, Jan-14, Volume: 1, Issue:8055

    Topics: Adult; Ampicillin; Colon, Sigmoid; Enterocolitis, Pseudomembranous; Humans; Male; Proctitis; Vancomycin

1978
Vancomycin for pseudomembranous colitis.
    Lancet (London, England), 1978, Jul-01, Volume: 2, Issue:8079

    Topics: Enterocolitis, Pseudomembranous; Female; Humans; Middle Aged; Vancomycin

1978
Oral vancomycin for antibiotic-associated pseudomembranous colitis.
    Lancet (London, England), 1978, Jul-29, Volume: 2, Issue:8083

    Topics: Administration, Oral; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; Cefazolin; Clindamycin; Enterocolitis, Pseudomembranous; Feces; Humans; Penicillins; Vancomycin

1978
Anion-exchange resins in pseudomembranous colitis.
    Lancet (London, England), 1978, Sep-16, Volume: 2, Issue:8090

    Topics: Anion Exchange Resins; Binding Sites; Cholestyramine Resin; Colestipol; Drug Evaluation; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; In Vitro Techniques; Intestinal Absorption; Ion Exchange Resins; Polyamines; Vancomycin

1978
Relapse of pseudomembranous colitis after vancomycin therapy.
    Lancet (London, England), 1979, Nov-17, Volume: 2, Issue:8151

    Topics: Administration, Oral; Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin

1979
Comparison of five regimens for treatment of experimental clindamycin-associated colitis.
    The Journal of infectious diseases, 1978, Volume: 138, Issue:1

    Topics: Animals; Antitoxins; Clindamycin; Clostridium perfringens; Colestipol; Cricetinae; Drug Evaluation; Enterocolitis, Pseudomembranous; Enterotoxins; Male; Mesocricetus; Methylprednisolone; Polyamines; Tetracycline; Vancomycin

1978
Therapy of antibiotic-associated pseudomembranous colitis.
    Journal of clinical gastroenterology, 1979, Volume: 1, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Cholestyramine Resin; Clostridium; Clostridium Infections; Colon; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Retrospective Studies; Vancomycin

1979
Relapse of pseudomembranous colitis after vancomycin therapy.
    The New England journal of medicine, 1979, Aug-23, Volume: 301, Issue:8

    Topics: Administration, Oral; Adult; Aged; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Feces; Humans; Recurrence; Time Factors; Vancomycin

1979
Morphology of experimental antibiotic-associated enterocolitis in the hamster: a model for human pseudomembranous colitis and antibiotic-associated diarrhoea.
    Gut, 1979, Volume: 20, Issue:6

    Topics: Animals; Cecum; Clindamycin; Clostridium Infections; Cricetinae; Diarrhea; Disease Models, Animal; Enterocolitis, Pseudomembranous; Intestinal Mucosa; Mesocricetus; Microscopy, Electron; Vancomycin

1979
Antibiotic susceptibility of Clostridium difficile.
    The Journal of antimicrobial chemotherapy, 1979, Volume: 5, Issue:3

    Topics: Anti-Bacterial Agents; Clostridium; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Miconazole; Microbial Sensitivity Tests; Vancomycin

1979
[Antibiotic-induced pseudomembranous Clostridium difficile colitis. A new etiopathogenetically definable infectious disease].
    Fortschritte der Medizin, 1979, Sep-06, Volume: 97, Issue:33

    Topics: Anaerobiosis; Animals; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridium; Enterocolitis, Pseudomembranous; Feces; Guinea Pigs; Humans; Metronidazole; Vancomycin

1979
Antibiotic-associated colitis--a review of 66 cases.
    The British journal of surgery, 1979, Volume: 66, Issue:10

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Clostridium; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Middle Aged; Vancomycin

1979
Antibiotic-associated colitis treated with oral vancomycin.
    The Journal of the Oklahoma State Medical Association, 1979, Volume: 72, Issue:12

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Female; Humans; Male; Staphylococcal Infections; Vancomycin

1979
Antibiotic-associated pseudomembranous colitis. Rapid clinical response to oral vancomycin.
    Arizona medicine, 1979, Volume: 36, Issue:11

    Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Vancomycin

1979
Experimental clindamycin-associated colitis in rabbits. Evidence of toxin-mediated mucosal damage.
    Gastroenterology, 1978, Volume: 74, Issue:2 Pt 1

    Topics: Animals; Autopsy; Bacterial Toxins; Cecum; Clindamycin; Clostridium; Colitis; Colon; Diarrhea; DNA; Enterocolitis, Pseudomembranous; Ileitis; Intestinal Mucosa; Male; Rabbits; Vancomycin

1978
Antibiotic-associated colitis: report of a case.
    The Journal of the Oklahoma State Medical Association, 1978, Volume: 71, Issue:12

    Topics: Amikacin; Enterobacteriaceae Infections; Enterocolitis, Pseudomembranous; Humans; Injections, Intraperitoneal; Kanamycin; Male; Middle Aged; Peritonitis; Vancomycin

1978
Pseudomembranous colitis: isolation of two species of cytotoxic clostridia and successful treatment with vancomycin.
    Canadian Medical Association journal, 1978, Nov-04, Volume: 119, Issue:9

    Topics: Aged; Animals; Clostridium; Clostridium Infections; Cricetinae; Culture Techniques; Diabetes Complications; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Leg Ulcer; Lincomycin; Vancomycin

1978
[Pseudo-membranous colitis: effective treatment with vancomycin].
    La Nouvelle presse medicale, 1978, Volume: 7, Issue:45

    Topics: Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Remission, Spontaneous; Vancomycin

1978
Clindamycin-induced colitis.
    The American journal of clinical nutrition, 1979, Volume: 32, Issue:1

    Topics: Animals; Bacterial Toxins; Cecum; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Mesocricetus; Metronidazole; Vancomycin

1979
Clindamycin-associated colitis in hamsters: protection with vancomycin.
    Gastroenterology, 1977, Volume: 73, Issue:4 Pt 1

    Topics: Animals; Clindamycin; Colon; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Gentamicins; Lincomycin; Male; Vancomycin

1977
The protective effect of vancomycin on clindamycin-induced colitis in hamsters.
    The Johns Hopkins medical journal, 1977, Volume: 141, Issue:4

    Topics: Administration, Oral; Animals; Clindamycin; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Enterocolitis, Pseudomembranous; Injections, Subcutaneous; Intestines; Male; Vancomycin

1977
Death from pseudomembranous enterocolitis.
    Obstetrics and gynecology, 1975, Volume: 45, Issue:6

    Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Castration; Cephalothin; Cesarean Section; Enterocolitis, Pseudomembranous; Fallopian Tubes; Female; Humans; Hysterectomy; Kanamycin; Methicillin; Middle Aged; Postoperative Complications; Pregnancy; Vancomycin

1975
Pseudomembranous colitis following resection for Hirschsprung's disease.
    Journal of pediatric surgery, 1992, Volume: 27, Issue:10

    Topics: Administration, Rectal; Child, Preschool; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Hirschsprung Disease; Humans; Intestinal Mucosa; Male; Metronidazole; Postoperative Complications; Reoperation; Vancomycin

1992
Ask the Pharmacist.
    American pharmacy, 1992, Volume: NS32, Issue:9

    Topics: Cholestyramine Resin; Colestipol; Enterocolitis, Pseudomembranous; Humans; Vancomycin

1992
Pseudomembranous enteritis: rediscovery of a previously well-described entity?
    The American journal of gastroenterology, 1992, Volume: 87, Issue:11

    Topics: Adult; Enterocolitis, Pseudomembranous; Female; Humans; Vancomycin

1992
[The diagnosis and treatment of Clostridium difficile enterocolitis].
    Zhonghua yi xue za zhi, 1991, Volume: 71, Issue:6

    Topics: Adult; Aged; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Vancomycin

1991
[A lethal course in pseudomembranous enterocolitis during the parenteral administration of vancomycin and imipenem].
    Deutsche medizinische Wochenschrift (1946), 1992, Jan-17, Volume: 117, Issue:3

    Topics: Colon; Combined Modality Therapy; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Imipenem; Infusions, Intravenous; Middle Aged; Postoperative Complications; Vancomycin

1992
[Clinical study of pseudomembranous colitis: a neurosurgical viewpoint].
    No shinkei geka. Neurological surgery, 1990, Volume: 18, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Brain Diseases; Cerebral Hemorrhage; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Postoperative Complications; Vancomycin

1990
Pseudomembranous colitis: how useful is endoscopy?
    Surgical endoscopy, 1990, Volume: 4, Issue:4

    Topics: Colonoscopy; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Sigmoidoscopy; Vancomycin

1990
Antibiotic-associated pseudomembranous colitis.
    American journal of diseases of children (1960), 1990, Volume: 144, Issue:5

    Topics: Administration, Oral; Costs and Cost Analysis; Enterocolitis, Pseudomembranous; Humans; Injections, Intravenous; Metronidazole; Vancomycin

1990
Inappropriate antibiotic use and the development of Clostridium difficile colitis.
    The West Virginia medical journal, 1990, Volume: 86, Issue:6

    Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Clostridium; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Retrospective Studies; Vancomycin

1990
[Antibiotic associated diarrhea].
    Annales de gastroenterologie et d'hepatologie, 1990, Volume: 26, Issue:4

    Topics: Anti-Bacterial Agents; Bacitracin; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin

1990
[Pseudomembranous colitis caused by antibiotic therapy during aorto-iliac surgery].
    Minerva chirurgica, 1990, May-31, Volume: 45, Issue:10

    Topics: Aorta, Abdominal; Blood Vessel Prosthesis; Cholestyramine Resin; Enterocolitis, Pseudomembranous; Humans; Iliac Artery; Metronidazole; Vancomycin

1990
Failure of intravenous vancomycin and intravenous metronidazole to prevent or treat antibiotic-associated pseudomembranous colitis.
    The Journal of infectious diseases, 1989, Volume: 159, Issue:6

    Topics: Enterocolitis, Pseudomembranous; Female; Humans; Injections, Intravenous; Male; Metronidazole; Middle Aged; Vancomycin

1989
Cost-effective treatment of pseudomembranous colitis.
    American family physician, 1989, Volume: 39, Issue:4

    Topics: Cost-Benefit Analysis; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Prospective Studies; Random Allocation; Vancomycin

1989
Treatment of Clostridium difficile diarrhea.
    The Medical letter on drugs and therapeutics, 1989, Oct-20, Volume: 31, Issue:803

    Topics: Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin

1989
Vancomycin for pseudomembranous colitis.
    Clinical pharmacy, 1989, Volume: 8, Issue:7

    Topics: Costs and Cost Analysis; Enterocolitis, Pseudomembranous; Humans; Vancomycin

1989
Treatment of Clostridium difficile colitis in hamsters with a lipopeptide antibiotic, LY146032.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Clindamycin; Cricetinae; Daptomycin; Disease Models, Animal; Enterocolitis, Pseudomembranous; Male; Mesocricetus; Peptides; Vancomycin

1987
LY146032 treatment of Clostridium difficile colitis in hamsters.
    European journal of clinical microbiology, 1987, Volume: 6, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Cricetinae; Daptomycin; Enterocolitis, Pseudomembranous; Male; Mesocricetus; Peptides; Vancomycin

1987
Chlorpropamide-induced cholestatic jaundice and pseudomembranous colitis.
    The American journal of gastroenterology, 1985, Volume: 80, Issue:5

    Topics: Chlorpropamide; Cholestasis; Enterocolitis, Pseudomembranous; Follow-Up Studies; Humans; Male; Middle Aged; Radiography; Sigmoidoscopy; Sulfasalazine; Sulfonamides; Vancomycin

1985
Clostridium difficile colitis secondary to intravenous vancomycin.
    Digestive diseases and sciences, 1989, Volume: 34, Issue:1

    Topics: Aged; Enterocolitis, Pseudomembranous; Humans; Male; Osteomyelitis; Vancomycin

1989
Comparison of the in vitro activities of teicoplanin and vancomycin against Clostridium difficile and their interactions with cholestyramine.
    Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:6

    Topics: Anti-Bacterial Agents; Cholestyramine Resin; Clostridium; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Glycopeptides; Humans; Teicoplanin; Vancomycin

1985
[Antibiotic-associated colitis and Clostridium difficile].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 1985, Volume: 7, Issue:4

    Topics: Adult; Aged; Clostridium; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Vancomycin

1985
Combined medical and surgical management of severe pseudomembranous colitis.
    The Pediatric infectious disease journal, 1988, Volume: 7, Issue:8

    Topics: Combined Modality Therapy; Enterocolitis, Pseudomembranous; Humans; Ileostomy; Infant; Intestinal Obstruction; Male; Vancomycin

1988
Oral vancomycin in prevention of necrotising enterocolitis.
    Archives of disease in childhood, 1988, Volume: 63, Issue:11

    Topics: Administration, Oral; Enterocolitis, Pseudomembranous; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Vancomycin

1988
Epidemiology and prevention of Clostridium difficile infections in a leukemia unit.
    European journal of clinical microbiology, 1987, Volume: 6, Issue:6

    Topics: Carrier State; Clostridium; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Hospital Units; Humans; Leukemia; Prospective Studies; Serotyping; Vancomycin

1987
Clostridium difficile colitis following treatment with metronidazole and vancomycin.
    Postgraduate medical journal, 1987, Volume: 63, Issue:745

    Topics: Adult; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Opportunistic Infections; Vancomycin

1987
Clostridium difficile colitis induced by cytarabine.
    American journal of clinical oncology, 1987, Volume: 10, Issue:5

    Topics: Aged; Cytarabine; Enterocolitis, Pseudomembranous; Humans; Leukemia, Myeloid; Male; Vancomycin

1987
CT-guided percutaneous catheter cecostomy.
    Gastrointestinal radiology, 1987, Volume: 12, Issue:2

    Topics: Aged; Catheterization; Cecum; Enterocolitis, Pseudomembranous; Evaluation Studies as Topic; Female; Humans; Methods; Tomography, X-Ray Computed; Vancomycin

1987
Vancomycin-induced pseudomembranous colitis.
    Journal of clinical gastroenterology, 1987, Volume: 9, Issue:1

    Topics: Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Vancomycin

1987
Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:1

    Topics: Animals; Bacterial Proteins; Bacterial Toxins; Clostridium; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Latex Fixation Tests; Recurrence; Saccharomyces; Vancomycin

1987
Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain.
    European journal of clinical microbiology, 1987, Volume: 6, Issue:1

    Topics: Aged; Aged, 80 and over; Clostridium; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Recurrence; Vancomycin

1987
Pseudomembranous colitis: local experience with 3 cases.
    The Medical journal of Malaysia, 1986, Volume: 41, Issue:4

    Topics: Aged; Enterocolitis, Pseudomembranous; Female; Humans; Intestinal Mucosa; Male; Metronidazole; Middle Aged; Sigmoidoscopy; Vancomycin

1986
Comparison of two antibiotic regimens for neonatal necrotizing enterocolitis.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 20, Issue:3

    Topics: Ampicillin; Anti-Bacterial Agents; Birth Weight; Cefotaxime; Clinical Protocols; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Feces; Gentamicins; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Newborn, Diseases; Vancomycin

1987
Pseudomembranous colitis & antibiotics.
    Kansas medicine : the journal of the Kansas Medical Society, 1986, Volume: 87, Issue:5

    Topics: Cefoxitin; Enema; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Vancomycin

1986
Changing epidemiology, diagnosis, and treatment of Clostridium difficile toxin-associated colitis.
    The British journal of surgery, 1986, Volume: 73, Issue:6

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacitracin; Bacterial Toxins; Child; Child, Preschool; Clostridium; Enterocolitis, Pseudomembranous; Female; Humans; Infant; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Vancomycin

1986
Vancomycin and necrotising enterocolitis.
    Archives of disease in childhood, 1986, Volume: 61, Issue:7

    Topics: Enterocolitis, Pseudomembranous; Humans; Infant, Newborn; Intestinal Absorption; Vancomycin

1986
[Relapsing pseudomembranous colitis in uremia].
    Harefuah, 1986, Apr-15, Volume: 110, Issue:8

    Topics: Cefotaxime; Cholestyramine Resin; Clindamycin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Uremia; Vancomycin

1986
A role for colonic stasis in the pathogenesis of disease related to Clostridium difficile.
    Diseases of the colon and rectum, 1986, Volume: 29, Issue:12

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Child; Child, Preschool; Clostridium Infections; Colon; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Motility; Humans; Infant; Male; Middle Aged; Risk; Vancomycin

1986
Pseudomembranous colitis following prophylactic antibiotic use in primary cesarean section.
    American journal of obstetrics and gynecology, 1985, Jan-01, Volume: 151, Issue:1

    Topics: Adult; Cesarean Section; Clostridium; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Postoperative Complications; Pregnancy; Vancomycin

1985
Antibiotic-associated pseudomembranous colitis.
    American family physician, 1985, Volume: 31, Issue:5

    Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; Bacterial Toxins; Cephalosporins; Cholestyramine Resin; Clindamycin; Clostridium; Colestipol; Endoscopy; Enterocolitis, Pseudomembranous; Feces; Humans; Leukocyte Count; Metronidazole; Vancomycin

1985
Pseudomembranous colitis in spinal cord injury.
    Archives of physical medicine and rehabilitation, 1985, Volume: 66, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Male; Quadriplegia; Spinal Cord Injuries; Vancomycin; Wounds, Gunshot

1985
Clostridium difficile colitis following head and neck surgery. Report of cases.
    Archives of otolaryngology (Chicago, Ill. : 1960), 1985, Volume: 111, Issue:8

    Topics: Aged; Anti-Bacterial Agents; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Head and Neck Neoplasms; Humans; Male; Metronidazole; Middle Aged; Postoperative Complications; Premedication; Vancomycin

1985
[Increasing incidence of pseudomembranous colitis and its association with antibiotic therapy].
    Harefuah, 1985, May-15, Volume: 108, Issue:10

    Topics: Clindamycin; Enterocolitis, Pseudomembranous; Humans; Israel; Postoperative Complications; Surgical Procedures, Operative; Vancomycin

1985
Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis.
    The American journal of gastroenterology, 1985, Volume: 80, Issue:11

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridium; Drug Administration Schedule; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Middle Aged; Recurrence; Spores, Bacterial; Vancomycin

1985
Clostridium difficile colitis associated with single-dose cefazolin prophylaxis.
    Obstetrics and gynecology, 1985, Volume: 66, Issue:5

    Topics: Adult; Cefazolin; Cesarean Section; Enterocolitis, Pseudomembranous; Female; Humans; Pregnancy; Premedication; Vancomycin

1985
Clostridium difficile-associated colitis in uremic patients.
    Clinical nephrology, 1985, Volume: 24, Issue:5

    Topics: Adult; Aged; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Uremia; Vancomycin

1985
[Studies on the hamster colitis model].
    Wei sheng wu xue bao = Acta microbiologica Sinica, 1985, Volume: 25, Issue:1

    Topics: Animals; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Female; Gentamicins; Male; Mesocricetus; Penicillin G; Vancomycin

1985
Staphylococcic (pseudomembranous) enterocolitis.
    Minnesota medicine, 1966, Volume: 49, Issue:6

    Topics: Enterocolitis, Pseudomembranous; Humans; Staphylococcal Infections; Vancomycin

1966
Staphylococcal enterocolitis--treatment with oral vancomycin.
    Annals of internal medicine, 1966, Volume: 65, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Staphylococcal Infections; Vancomycin

1966